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ABSTRACT 
Cyanine dyes have been used for labeling biomolecules such as proteins and DNA. The 
fluorescent properties and possibility of photosensitization by these molecules made them 
candidate drugs in image-guided surgery and in photodynamic therapy (PDT). In this study, we 
are exploring the theranostic properties of novel cyanine dyes with a goal to find near infrared 
photo nucleases in order to achieve an ideal photosensitizer that could be potentially used in 
PDT. Duplex DNA photo cleavage by pentamethine bridged near infrared cyanine dye was 
investigated. The detailed chemistry of dyes photo physical and photochemical properties, 
mechanism of dye-DNA interactions, DNA binding modes, and species involved in photo 
cleavage reactions were studied. The effects of different types of heterocyclic rings, variation in 
the length of the polymethine bridge, and the effect of electron withdrawing substitution on the 
dyes were investigated with a goal to achieve a new generation NIR drugs in photo therapy. 
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1 
1 CHAPTER 1: INTRODUCTION  
Imaging and phototherapy by the same sensitizer is being sought so that simultaneous 
diagnosis and treatment of cancer is possible upon irradiating a sensitizer. Near-infrared 
polymethine bridged cyanine dyes could be the potential candidates for this kind of approach as 
they are good photosensitizers (PS) and are potential fluorescent agents. Conventional cancer 
drugs that exert therapeutic effect through interaction with DNA can inhibit the replication of 
DNA or prevent DNA transcription by forming DNA strand cross-links, mono-adducts, and 
strand breaks. DNA binding drugs such as cisplatin, mitomycin, mustine, adriamycin, and 
bleomycin typically have significant numbers of side effects such as kidney, lung and liver 
damage, cardiotoxicity, gastrointestinal distress, and permanent infertility.1,2,3 As a result, 
scientists are searching for noninvasive therapeutic techniques that can prevent the growth of 
tumors while minimizing side effects. In the early 1950s, Figge et al. showed the tumor 
localizing property of hematoporphyrin, when it is topically injected into tumor tissue.4,5 After 
the discovery of hematoporphyrin, for many decades, DNA damage induced by photosensitizers 
included but was not limited to flavins, porphyrins, quinones, tetracyclines, thiazides, and several 
metal complexes.6,7 This led to a new therapeutic approach called photodynamic therapy, which 
mainly uses three mechanisms to kill disease-infected cells. First, the photosensitizer (PS) enters 
the cells then produces reactive oxygen species (ROS) that cause cell death. Second, PS can 
destroy the tumor vasculature system resulting in the lack of oxygen and nutrients supply in the 
tumor cells which ultimately lead to their death. Third, PS can trigger an immune response 
against the cancer cells.  
Metal complexes containing ions of rhodium, cobalt, ruthenium, vanadium, and iron have 
been extensively studied for their photo nuclease potentials. For example, cis-[Rh2(μ-
2 
O2CCH3)2(dppz)(ɳ
1-O2CCH3)(CH3OH)]
+ , cis-[Rh2(m-O2CCH3)2(dppz)2]
2+, and ∆-
[Rh(en)2phi]
3+ complexes damage DNA strands when excited by λirr > 395 nm.
8 Similarly, Chang 
et al. showed that the complex of Co(III)-bleomycin9 damages the sugar ring of DNA by 
hydrogen abstraction when photoexcited with 366 nm light. Kelly and co-workers found that 
Ru(bpy)3
2+ photo damages  DNA strands by the generation of reactive oxygen species.10 
Although these metal complexes cause DNA damage through photoexcitation at a certain 
wavelength, the problems with metal complexes as therapeutic agents are that they have 
relatively high dark toxicity, low molar absorptivity, low stability, and long retention times. 
Again, most of the metal complexes absorb light at less than 700 nm which is not suitable for 
deep light penetration into compact tumor tissue. To mitigate issues of high dark toxicity, 
undesirable side reactions and long retention times, chemists thought of long wavelength non-
metallated photo cleaving compounds which could have properties such as therapeutic sensitivity 
and higher molar absorptivity. In search of such a candidate, naphthalimide, anthryl, 
benzotriazole, porphyrin, and other ring systems have been studied.6,7 Among these organic 
compounds, the most promising and commonly used FDA approved drug is the porphyrin 
derivative, porfimer sodium known by trade name Photofrin®.11 It has been used as a 
phototherapeutic agent for the treatment of esophageal and non-small cell lung carcinomas. 
Verteprofin, methyl aminolevulinate, Temoporphin, Talaporphin, and Ce6-PVP are also being 
used to treat a variety of tumors and approved by drug regulatory agencies around the globe 
(Table 1).12 Though useful in the treatment of cancer, the problem with these drugs is that the 
tumor remission rate is low for early stage cancers.13 In addition to that, these drugs have 
relatively high dark toxicity, difficulties in passing through the cell membrane, stability issues, 
and lower molecular absorbance above 700 nm. To address these issues, scientist envisioned the 
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creation of an ideal PS with the following properties: amphiphilicity, absorption and ROS 
production in the near-infrared range, minimal dark toxicity, selective retention by tumor cells, 
stability in physiological environments, and reasonable interactions with biomolecules. 
 
 
 
 
 
 
 
 
In 1958, Indocyanine green (IC-Green), a well-known cyanine dye, was submitted to the 
FDA for the approval of its use in an indicator-dilution study on humans. Nowadays, 
Indocyanine green, Cy3, Cy5, Cy7, and many cyanine family dyes have been employed as 
fluorophores in biomolecular labeling.14 In addition to that, several heptamethine and 
pentamethine cyanine dyes including IC-Green are being studied in preclinical phases for their 
diagnostic application and potentiality in PDT.15 The properties like low toxicity, highly 
conjugated structure with high molar absorptivity, easy structural manipulation, near infrared 
absorption, and selective retention in tumor cells, made cyanine dyes good candidates in search 
of future idealistic phototherapeutic agents and fluorescent markers.  
The idea of DNA as a cleaving target has started since its discovery and structural 
deconvolution. DNA is such a lucrative object that can be utilized in a large number of 
biomolecular technologies. The study of the DNA-drug interactions emerged as a major field 
Table 1 FDA approved photosensitizers 
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with the hope to treat the diseases that might potentially involve DNA. In this project, we are 
trying to understand the mechanism of DNA-small molecule (cyanine dye) interactions in pursuit 
of near-infrared DNA photo cleaving agents. 
1.1 Mechanism and principle of PDT 
The mechanism of tumor cells death starts with the absorption of light by photosensitizer 
in photodynamic therapy (PDT). The suitable wavelength of light excites the PS into higher 
singlet energy state which then either can go back to the ground state (S0) by internal conversion 
and/or fluorescence emission or can go to triplet state (T1) by intersystem crossing (Fig 1).
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Once in the triplet state, the PS might follow multiple fates: 1) it can go back to ground singlet 
state by phosphorescence mechanism, 2) it can transfer energy by type II pathway to the 
available surrounding triplet ground state molecular oxygen to produce excited singlet state 
oxygen (1O2), 3) the PS can ransfer electrons (type I) to nearby molecules and produce radicals 
and radical ions.12,17 In a type I reaction, excited triplet state sensitizer (3PS*) transfers the 
electron to the ground state oxygen to produce superoxide anion (O2
•-) which then spontaneously 
forms H2O2 through dismutation. The H2O2 then produces hydroxyl radical (
•OH) through 
Fenton type redox reactions with metal ions (Scheme 1). In Type II photosensitization process, 
singlet oxygen (1O2) is formed upon energy transfer from 
3PS* to 3O2. The diffusion distances of 
1O2 and •OH in the biological system are < 20 nm and 0.8-6.0 nm respectively.
18,19 
3PS* + 3O2 → 
3PS*+ + O2
•- 
Fe3+ + O2
•- → Fe2+ + 3O2 
2O2
•- + 2H+ → H2O2 + 
3O2 
Fe2+ + H2O2 → Fe
3+ + •OH + OH- 
Scheme 1 Mechanism of ROS generation 
5 
 
 
 
 
 
 
 
 
Reactive oxygen species (ROS) in biological systems can be harmful or beneficial. Some 
of the examples of ROS playing benign roles are when they act against infectious foreign 
material, help in signaling mechanisms, and induce a mitogenic response. At high 
concentrations, they can cause oxidative damage to DNA, proteins, lipids, and carbohydrates. 
Hydroxyl radicals have a lifetime lower than 1 ns and singlet oxygen has a lifetime lower than 40 
ns in physiological conditions. 
 
 
 
 
M. Dizdaroglu et al. studied in detail about the mechanism and possible products 
generated by radical-induced damage to DNA by using chromatographic and mass spectrometric 
techniques. Several products have been reported to be generated by ROS damage to DNA that 
include single or double stranded DNA breakage, purine, pyrimidine or deoxyribose sugar 
modifications, and DNA crosslinks. Addition of hydroxyl radicals generates OH-adduct radicals 
Figure 1 Jabolonski diagram showing ROS production in PDT. 
Figure 2 Reaction of guanine with hydroxyl radical. 
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of DNA bases whereas the abstraction of hydrogen by •OH generates allyl radicals of thymine 
bases and carbon-centered sugar radicals. Hydroxyl radicals can add to the C-5 and C-6 positions 
of pyrimidine bases which then react with oxygen and water giving pyrimidine glycol products. 
Similarly, •OH can react with purine bases at C-4, C-5 and C-8 positions forming hydroxyl 
adduct radicals; then those adducts can further oxidize to form hydroxypurine (Fig 2).19 
Abstraction of an H-atom from the sugar carbon atoms (Fig 3, Fig 4)20 can lead to the formation 
of carbon-centered deoxyribose sugar free radicals that can further react to cause strand breakage 
or produce base free DNA strands.20 Moreover, a cross-link of thymine-tyrosine was reported in 
an in vitro study in mammalian chromatin and cells when exposed to free radicals. This 
suggested that DNA bases and protein cross-link are possible when those molecules are exposed 
to ROS. 19,20 
 
 
 
 
 
 
 
Triplet excited photosensitizers can follow the type II pathway to transfer energy to the 
ground state triplet oxygen to form high energy excited state singlet oxygen (1O2). The biological 
roles of singlet oxygen are reported by L.F. Yamaguchi as “involvement in defensive mechanism 
phagocytosis, hormonal activity of prostaglandins, clinical manifestations of toxic agents like 
psoralens and inborn errors of metabolism exemplified by erythropoietic porphyria.” The 
Figure 3 Structures of the free radical induced product of the sugar moiety of 
DNA. 
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electrophilicity of singlet oxygen makes it prone to attack proteins, unsaturated fatty acids, 
enzymes. Singlet oxygen also reacts with DNA and causes direct strand breakage. The 
mechanism of the singlet oxygen damaging DNA bases is shown below (Fig 5).21 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PDT involves three components: (i) photosensitizer (PS), (ii) light of suitable 
wavelength, and (iii) molecular oxygen. PDT is a two-stage process; first a PS is localized into a 
tumor tissue then a light of suitable wavelength is used to generate ROS that causes the 
Figure 4 The mechanism of formation of 8, 5’-cyclodeoxyguanosine. 
Figure 5 Mechanism of DNA damage by singlet oxygen. 
8 
remission of tumor cells. As shown in Fig. 6, cells death can be explained by three mechanistic 
pathways:  
 
 
 
 
 
 
 
 
 
 
1. Apoptosis: This is a controlled death of the cell via a highly regulated mechanism. This path 
of cell death is followed when PS accumulate into the mitochondria which is a major apoptotic 
signal generator organelle in the cell. Once the mitochondria are damaged, they can excrete 
cytochrome C into the cytosol that can trigger cell death.  
2. Necrosis: A burst of ROS on the plasma membrane of the cell can cause this kind of cell 
death. The oxidative stress caused by the ROS can damage multiple cell organelles including the 
cell membrane. The leakage of cellular pro-oxidants into the surrounding environment that 
uncontrolled destruction of surrounding cells results in this kind of cell death .12,22 
3. Autophagy: The third kind of cell death is called autophagy. This is the process where the 
recycling of damaged cell material happens with the help of immune cells called 
Figure 6 Schematic representation of the processes involved in PDT. 
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autophagosome.12Autophagosomes delivers abnormal cytoplasmic contents into lysosomes 
where lysosomal hydrolases degrade the contents. 
1.2 Factors affecting PDT efficacy 
PS, in general, are administered by intravenous, topical or intraperitoneal pathways. Once 
in the body, it can be retained by healthy or tumor cells in the same amounts, but the retention 
time in the healthy cells is shorter as compared to the tumor cells because of the nonexistent 
lymphatic system and high metabolism in tumor cells as compared to healthy cells. This 
behavior of PS combined with localized irradiation of light on the tumor tissue gives selective 
tissue damage. Three mechanisms of tumor destruction by PDT are proposed: (a) ROS mediated 
damage of cell organelles that triggers cell death through apoptosis or necrosis or 
autophagosomes, (b) lack of oxygen and nutrients due to destruction of tumor tissue vasculature 
that cause the blockage of supply lines, and (c) PS-mediated signaling that triggers the immune 
response to tumor cells. 
1.2.1 Light 
Phototherapeutic window lies between 650 nm – 915 nm because in this window light 
has maximum penetration depth in the tissue. As shown in Fig. 7, most of the chromophores in 
biomolecules absorb light below 650 nm, and the main solvent, water absorbs light above 915 
nm. 23 Hemoglobin and melanin are the two main biomolecules that can absorb light up to the 
near infrared range. Above 915 nm water absorption increases rapidly. The variation of the tissue 
penetration depth depends on the type of organs also. For example, light has higher penetration 
through liver tissue as compared to bones. Even with the most transparent tissue in the body, 
light cannot pass more than 10-15 mm. For the early stage cancers that can be targeted with a 
light source (e.g., live, bladder, lung, esophageal, squamous cell cancers), there is less of a 
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problem for the near-infrared light to penetrate the tissue, but for the late stage cancers or cancers 
at the center of solid organs such as prostate and pancreases, it is a major issue. In those cases, 
thin needles with diffusion laser fibers can be used to help pass light onto the targeted sites. In 
case of squamous cell skin cancer, LED lights are mostly used but other than that laser light 
source are usually employed to deliver the light of an appropriate wavelength. The patient after 
the PDT might have to be cautious about exposure to sunlight. Some of the PS might stay inside 
the body for a long time, and if an appropriate wavelength of light contacts the body where PS is 
localized, it might damage the healthy tissue. 24,25 
 
 
 
 
 
 
 
 
 
 
 
1.2.2 Photosensitizer structure, localization and uptake 
Photosensitizers are chosen based on their photochemical and photophysical properties. 
As previously mentioned, an ideal photosensitizer is considered based on its purity, chemical 
stability, ability to absorb light in NIR region, ability to generate ROS, selectivity for disease 
Figure 7 Phototherapeutic window. 
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infected cells, minimal dark toxicity, rapid accumulation in diseased cells in a short period, and 
faster clearance from the body. Several molecular structures are considered based on their 
abilities to absorb light and interact with biomolecules for phototherapeutic treatment. The 
charge and polarity of the PS are critical in terms of its localization, distribution, and therapeutic 
potential. Hydrophilic drugs are capable of binding to outside of cell membrane due to their 
limitation of passing through phospholipid bilayer. These kinds of compounds can bind to serum 
albumin which can eventually block the tumor tissue vasculature system. On the other hand, 
lipophilic drugs are capable of penetrating inside cells and can accumulate into cell organelles 
causing generation of ROS inside the cell that can trigger apoptosis or necrosis depending upon 
the cell organelle. It is considered that the most versatile type of PS is amphiphilic because of the 
potential to penetrate through the plasma membrane and bind to the different cell organelles such 
as mitochondria, the Golgi apparatus, and the endoplasmic reticulum. Sensitizers that target the 
mitochondria can damage the mitochondrial membrane leading to the pro-apoptotic cell death 
while a sensitizer that accumulates inside the endoplasmic reticulum can release cellular calcium 
into the cytoplasm leading to necrosis. Some sensitizers can accumulate inside the lysosome 
releasing hydrolytic acidic enzymes causing cell death similar to autophagy. Oxygen level is 
another most important factor in PDT. Lower partial oxygen pressure in PDT treated tumor cells 
was reported, suggesting that oxygen consumption occurs during PDT. Lower partial O2 pressure 
after the PDT also indicates the success of PDT when treating tumor cells.23 
1.3 FDA and internationally approved photosensitizers and the current state of clinical 
trials 
FDA approval of a drug can take many years (Fig 9, (https://www.fda.gov/patients/learn-
about-drug-and-device-approvals/drug-development-process)). Dougherty et al. in 1970 used a 
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hematoporphyrin derivative (hematoporphyrin mixed with acetic acid and sulfuric acid) to treat a 
mammary tumor in a group of mice. The successful remissions of tumors in mice lead to clinical 
trials in human skin cancer. Out of 113 total tumors, 98 tumors were completely eradicated, 13 
had undergone partial remission, and two appeared PDT resistant. After this finding, the 
government of Canada in 1993 approved Photofrin as a photosensitizer for the treatment of 
bladder cancer (Fig 8).25,11 
 
 
 
 
 
 
 
 
 
 
 
Robinson et al. (2017) reported 58 ongoing clinical trials throughout the world in different 
phases using 11 different types of photosensitizers. They also reported that most of the 
photosensitizers being studied were either Photofrin® or ALA derivatives. Despite that several 
drugs were under consideration for their potential use in the PDT, as of 12/16/2016 only four 
drugs were approved by the FDA: 12,25 Profimer sodium, 5-ALA, Metvix, and verteprofin. In 
addition to that, Redaporfin®, Foscan®, and synthetic hypericin (SGX301) are approved in EU, 
Figure 8 Structures of FDA approved photosensitizers. 
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Laserphyrin® is approved in Japan, and aluminium sulfonated phthalocyanine is approved in 
Russia for the marketing.12,25 
1. Lung 
Palliative treatments that include Photofrin®-PDT and Radachlorin®-PDT are found 
effective against both early stage and advanced non-small cell lung cancer. In addition to that, as 
of 2017, palladium-bacteriochlorophyll WST11 (EudraCT ID: 2009-011895-31) and Fotolon® 
(Chlorin e6-PVP) were being investigated in the EU for the treatment of non-small cell lung 
cancer (EudraCT ID: 2013-001876-39).12,26 
2. Esophageal 
Mainly Photofrin®-PDT and 5-ALA both showed good efficacy against Barret’s 
esophagus and early esophageal cancer (EudraCT ID: 2005-005528-15). Another, 
photosensitizer talaporfin was in the phase I clinical trial for the treatment of esophageal cancer 
as of 2017.12 
3. Skin 
Skin cancer is mainly divided into two types: melanoma and non-melanoma. ALA-PDT 
(5-aminolevulinic acid) has been approved for the treatment of actinic keratosis. methyl 
aminolaevulinate (MAL), a derivative of ALA and BF-200 ALA, a nanoemulsion based gel 
formulation containing ALA, are currently being investigated for the treatment of non-melanoma 
skin cancer and actinic keratosis in the US (ClinicalTrials.gov: NCT02367547 and 
NCT02647151).12,27 
4. Head and neck (HNC) 
5-ALA and mTHPC (Foscan®) are being used in the treatment of HNC cancer.28 
Recently, 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide was found effective against oral 
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squamous cell carcinoma. Redaporphin® is also being investigated for its tolerability, 
pharmacokinetics, and antitumor activity (EudraCT ID: 2013-003133-14).12 Arshad et al. (2016) 
presented two case studies for the treatment of cancer in the head and neck region. In the first 
case, a patient with T2 mucossa squamous cell carcinoma (SCC) was treated with porfimer 
sodium. The laser light used was 639 nm with the power output of 150 mW / cm2. After 6 
months of treatment, the patient was reported to be disease free with minimal scarring. Another 
patient with T2 glottic SCC was also treated using porfimer sodium under the same conditions as 
the previous patient and in this case, also the complete remission of the tumor was reported. 24 
5. Bile duct, pancreas, prostate, and other cancers 
Several clinical investigations are being conducted for the treatment of cancers including 
bile duct, pancreatic, and prostate cancers. Out of those, some of the clinical trials are worth 
special mention. In Phase II trial, the use of temoporfin (Foscan®)-PDT and deuteporfin-PDT is 
going on for the treatment of bile duct cancer (Clinicaltrials.gov ID: NCT02955771). Similarly, 
Verteporfin® is being investigated in Phase I and Phase II clinical trials for the treatment of 
pancreatic cancer (EudraCT ID: 2006-004097-28). In addition to that, a currently ongoing study 
is investigating the use of hypericin in patients with muscle-invasive urothelial cell carcinoma 
(EudraCT ID: 2007-001302-25). The most popular drug Photofrin® is also being investigated in 
the US for its possible use in the treatment of brain cancer (Clinicaltrials.gov ID: 
NCT01966809).12,25,29 
1.4 Current Limitations of PDT 
Though PDT has noninvasive advantage over surgery, radiotherapy, and chemotherapy for 
the treatment of cancers, it is still less effective for late-stage bulky tumors. Skin photosensitivity 
is one of the main side effects of first-generation PS as they remain inside the body for a long 
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amount of time and also be activated by visible light. If a newly treated patient is exposed to 
sunlight, PS accumulated in the healthy tissue might be activated and can cause damage. This 
mostly happens where the PS cannot pass the plasma membrane of cells and remains in the 
vasculature system of the tumor tissue. Most of the first generation photosensitizers have this 
kind of longer retention issue. Another important factor for the treatment of compact tissue 
tumors and late-stage cancer is the light penetration depth. Three things are important in PDT: 
light, PS and oxygen level. If the PS is activated by a wavelength of less than 700 nm light, it can 
be expected that this light cannot effectively penetrate the bulky tumors, resulting in reduced 
efficacy in treating late stage cancer or compact tissue cancer. Hydrophobicity is also a major 
factor for photosensitizers that contain porphyrin or chlorin rings. They tend to aggregate in the 
cytoplasm after entering via the plasma membrane resulting in difficulties in interacting with the 
hydrophilic cellular fluid. This decreases the chances of drug targeting a specific biomolecule, 
hence the efficacy of the drug. To minimize these limitations, specificity of drugs for targeting 
tumor cells is being investigated by using a variety of approaches such as the conjugation of 
drugs to the receptor-ligand peptides, monoclonal antibodies, carrier proteins, carbohydrates, or 
by loading into targeted nanoparticles (NP). 
 
 
 
 
 
 
 
Table 2 FDA drug approval process  
16 
1.5 Types of photo nucleases and photosensitizers 
Two approaches have been employed for the administration and excitation of 
photosensitizer in the disease infected tissue. In first approach, direct administration of a PS is 
followed by irradiation of suitable wavelength of light that generates reactive oxygen species 
resulting in the damage of diseased cells biomolecules including DNA. The second strategy 
involves the covalent attachment of a PS into a high affinity compounds such as intercalators, 
organic cations, peptides and proteins, DNA minor groove binders, and oligonucleotides with a 
natural or modified backbone, followed by administration and light excitation. A paper published 
by Maurizio Prato et al. in 2001 presented a review of photocleaving agents with respect to DNA 
as a targeted biomolecule. In 2016, Li and Grant published a review paper on long wavelength 
DNA photo cleaving agents. They mainly presented two kinds of photo nucleases: metal 
complexes and organic compounds. 
1. Metal complexes  
(A) Rhodium complexes 
Rh(II) complexes containing polycyclic aromatic ligands are one of the most researched 
photo nuclease agents that contain metal ions. D-[Rh(en)2phi]3
+ is one of the well-known photo 
nuclease that has a rhodium metal ion in its center. This rhodium complex is found to be 
selective binding to 5’–GC–3’ sequences. Brewer and co-worker showed that 
[(bpy)2Os(dpp)RhCl2(phen)]3 
 photo cleaves DNA at 645 nm in anaerobic conditions. Several Rh 
complexes with the wide variety of ligands have been studied and most of them showed DNA 
photocleavage with or without oxygen below 500 nm.7,8 
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(B) Cobalt complexes 
A complex of Co(III)-bleomycin was investigated for its photo interaction with 
biomolecules by Chang et al. in 1980. Other three analogous Co(III)-bleomycin complexes, 
named Co-PMAH complexes, were found to cleave DNA at around 500 nm. Co(II)/Co(III) 
complexes of anthryl or anthraquinone derivatives were also reported to damage the DNA at a 
wavelength around the lower visible range. Another cobalt complex, hexamminecobalt(III) 
chloride was found to cleave DNA selectively in 3’-AG-5’ sites (Fig 10).7 
 
 
 
 
 
(C) Ruthenium complexes 
Ru(II) complexes containing tris-bipyridyl or trisphenanthroline ligands were reported to 
generate ROS and were capable of inflicting damage to biomolecules (Fig 11). Kelly and 
coworkers demonstrated that Ru(tap)3
2+ showed higher photo cleavage than Ru(phen)3
2+ or 
Ru(bpy)3
2+. A recent publication by Brabec and co-workers talked in detail about dimethyl 
Figure 9 A generic tris complex containing rhodium with 
representative ligands (phenanthrenequinone diamine 
(phi) and phenanthroline (phen)). 
Figure 10 Cobalt complex. 
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sulfoxide, imidazole, indole, arene, dinuclear and polypyridyl complexes of ruthenium and their 
photo nuclease activity. Most of the complexes of ruthenium were found to cleave DNA in the 
UV-visible region at ≤ 400 nm photosensitization wavelengths.7,30 
 
 
 
 
 
 
 
 
 
 
(D) Lutetium complexes 
Lutetium(II) complexes were studied as potential NIR photosensitizers that could be used 
in PDT. The paper by Magda et al. presented a pBR322 plasmid DNA photocleavage study in 
which DNA was photosensitized by lutetium texaphyrin. Samples were irradiated with 700 nm 
light (280 mW/cm2) and the maximum photocleavage yield was 93%.31 Lutetium texaphyrin 
(motexafin lutetium) (Fig 12) was reported to be approved for clinical trials after the approval of 
the investigational new drug application by the FDA. After the successful investigation of these 
drugs in the preclinical phase, these drugs were included in a clinical trial for the treatment of 
adenocarcinoma of the prostate, cervical cancer, and advanced adult primary liver cancer 
(https://clinicaltrials.gov/ct2/results?cond=&term=Lutex%C2%AE&cntry=&state=&city=&dist
Figure 11 Ruthenium complexes and ligands: generic tris-
ligand complex (a), trans and cis-[Ru(II)((CH3)2SO)4Cl2] 
(b,d), [(ɳ6-p-cymene)2Cl2Ru2 naphthazarin] (c), 2,2’-
bipyridine (e), and phenanthroline (f). 
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=). The drug named lutetium (III) texaphyrin has an absorption maximum in a range of 700 nm – 
800 nm and a molar absorptivity of 42000 M-1cm-1. The current clinical trial status shows that 
the clinical trial for both of these drugs were terminated.6 
 
 
 
 
 
 
 
(E) Copper and iron complexes 
Chakravarty and co-workers designed iron(III) and copper(II) complexes that can damage 
DNA up to 785 nm. Since these metal ions can be reduced in the presence of biogenic reducing 
agents, their complexes have shown high dark toxicity. Chakravarty and coworkers first 
synthesized polypyridyl complexes of Cu(II). Then, later on, Cu(II) bis-dipyridoquinoxaline 
(dpq) complex (Fig 13b) and Cu (II) Schiff base-phenanthroline (phen) complex were studied 
but they also showed high dark toxicity. In 2005, Chakravarty's group synthesized a square 
planar binuclear disulfide copper(II) complex, and in a 2009 follow-up study, Chakravarty's 
group designed a series of binuclear copper(II) complexes with the photocleaving capability up 
to 750 nm. They also reported the synthesis of ternary iron(III) complex (Fig 13a) which was 
capable of photocleaving nucleic acids at 785 nm.7,6 
 
 
Figure 12 Structure of lutetium(III) texaphyrin. 
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(F) Vanadium complexes 
Chakravarty and coworkers synthesized series of OV(IV) complexes with O, N, O-donor 
α-amino acid Schiff base and N, N-donor polypyridyl ligands, and studied their photo nuclease 
properties. The best performing photo nuclease in the series was [VO (salmet) (dppz)] (Fig 14a), 
where salmet is N-salicylidene-L-methionate and dppz is dipyridophenazine. This drug was 
capable of cleaving DNA at 799 nm. In 2016, Oxovanadium (IV) complexes, [VO(L1)Cl2] (Fig 
14c) and [VO(L2)Cl2] (Fig 14b), where L1 is N,N,N-donor benzyldipicolylamine and L2 is 
N,N,N-donor base (8-{[bis(2-pyridylmethyl)amino]methylphenyl}-4,4-difluoro-1,3,5,7-
tetramethyl-4-bora-3a,4a-diaza-s-indacene), were reported by Chakravarty  and coworkers. They 
also reported that these compounds were capable of producing reactive oxygen species and cause 
DNA damage when irradiated by visible light (400-700 nm). 6,32 
 
 
 
 
 
 
Figure 13 Structures of the (a) iron complex and (b) copper complex. 
Figure 14 Oxo vanadium complexes. 
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2. Organic compounds 
A series of anthraquinone derivatives were found to intercalate between DNA base pairs. 
Due to a strong hydrophobic interaction between anthraquinones and DNA base pairs, scientists 
started to explore the toxicity of these chromophores in biological systems. When irradiated with 
an appropriate wavelength of light, some of the anthraquinone were able to damage the DNA. 
Schuster and coworkers studied the series of anthraquinone derivatives and found some (Fig.15) 
were capable of photocleaving DNA.33 Similarly, Kelly and coworkers performed a study of 
photo processes of some naphthalimide derivatives in aqueous solutions of DNA and found that 
several exhibited photonuclease activity.34 Kumar and coworkers studied the photocleavage 
properties of anthryl compounds35 while Manfredini et al. studied photocleavage of some 
benzotriazole triazole derivatives.36 All of the organic compounds mentioned above were found 
to photocleave DNA in UV-visible range. In addition to that, several other non-mentalated 
compounds were studied for their photocleavage properties in UV-visible range including 
quinolines, quinoxalines, and diazo derivatives.7,6 
 
 
 
 
 
 
 
 
 
Figure 15 Representative pictures of DNA photocleavage 
capable organic compounds. 
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1.6 Cyanine derivatives 
Grant and Lorente in 2008 published a paper that shows synthesis and photo nuclease 
properties of an organic bis-(phenothiazinium)ethylenedipiperidine salt. According to their 
study, this compound is a bis-intercalator and can cleave DNA at 710 nm with the average 
percentage cleavage of 93% (Ɛmax 145,000 M
-1Cm-1 at 675 nm).37 After this finding, Dr. Grant 
and her group started to envision the possibility of discovering additional compounds that can 
cleave the DNA in the NIR range. The concept of the image-guided noninvasive therapeutic 
technique by using NIR dyes was long talked. In Dr. Grant's lab, the group started to work on 
molecules that have high molar absorbance at NIR range.  
After the FDA approval of indocyanine green dye (IC-Green) in 1959 for the clinical 
diagnosis, the focus shifted on finding theranostic drugs. Theranostic drugs can simultaneously 
diagnose and treat tumor infected tissue. Although MRI and CT scans are the most used 
diagnostic techniques that are reliable and highly advanced, during surgery, a surgeon has to 
depend on palpation and visual inspection to identify and remove disease infected tissue. Errors 
can lead to incomplete tumor resection or unwanted removal of healthy tissue. To mitigate this 
problem, scientists have thought about using NIR fluorescent dyes to diagnose and map the 
diseased tissue. So far in addition to IC-Green, methylene blue, 5-ALA, and fluorescein sodium 
are approved by FDA as contrast agents and are being used for fluorescence imaging of tumor 
tissues.15 The emission wavelengths of 5-ALA, methylene blue, IC-Green, and fluorescein 
sodium are 635, 680, 820, and 520 nm respectively.15 IC-Green (Fig 16(1)) is being mostly used 
as sentinel lymph node (SLN) mapping. Several reported SLN mapping studies have been 
reported in the clinical trial phase. Among them head and neck, esophageal, lung, cervical, 
prostate, bladder cancers are worth mentioning. Although there have been various reports of 
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target-specific imaging using antibodies or peptides being studied in preclinical phases, the FDA 
has not approved them for the clinical diagnostic purpose. So far only methylene blue, IC-Green, 
fluorescein sodium, and 5-ALA, which are nonspecific contrasting agent, are being widely used 
in clinical trials.38,15 In 2018, Rooster and coworkers, experimented SLN mapping using IC-
Green in six healthy dogs. They found that IC-Green is safe, sensitive, practical and inexpensive 
in NIR imaging of SLN.39 
In a 2019 paper, Shen and coworkers studied the ROS production and possible antitumor 
effects of IC-Green. IC-Green is relatively unstable, with around 2-3 min of cytoplasmic half-
life, is non-ligand specific, and is self-aggregable under physiological conditions. Since stability 
is major issue for phototherapeutic drugs, the researchers have tried to enhance the stability of 
the IC-Green using thermosensitive hydrogel, consisting of a conjugated polymer of poly(N-
phenylglycine).40 In their experiment, they claimed that IC-Green stabilized by polymer hydrogel 
was efficient in the treatment of a 4T1 tumor that was induced in mice when the PS was 
irradiated by 808 nm light. Moreover, they claimed that they detected the production of 1O2 by 
using singlet oxygen capturing agent 1,3-diphenylisobenzofuran when IC-Green loaded in the 
hydrogel was irradiated with 808 nm laser light in vitro.40 
 
 
 
 
 
 
Figure 16 Structures of (1) Indocyanine green (IC-Green) (2) meso-Cl cyanine dye. 
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In addition to IC-Green, several other trimethine (Cy3), pentamethine (Cy5) and 
heptamethine (Cy7) dyes are being used in biomolecular labeling and quantification. Recently, 
their potency in PDT has been of great interest. Burges et al. claimed that  heptamethine meso-Cl 
dye (Fig. 16(2)) was capable of site-specific binding with a protein that has a free cysteine 
residue. They hypothesized that meso-Cl group of cyanine dye can be substituted by nucleophilic 
functional groups of amino acids.41 Normally, with the cyanine dyes, coupling functionalities 
such as maleimide, succinimide esters, isocyanates, or sulfonyl halides are added on the ring 
nitrogens to make them able to covalently bond with antibodies, proteins, enzymes or 
nucleotides. This way they can be used in molecular labeling and quantification.  
1.7 Cyanine dyes and their properties 
Cyanine dyes are the group of compounds that contain polymethine bridges, generally 
connecting N-containing heterocyclic rings. Different substituents at various positions of 
heterocycles are sometimes placed to improve dye stability and/or interactions with target 
biomolecules. Cyanine dyes have characteristic features consisting of positive charge, aromatic 
heterocyclic ring with heteroatom conjugated by methylene bridges (Fig 17). 
 
 
 
 
Cyanine dyes can interact with DNA through intercalation, groove, and/or external 
binding modes as they contain planar heterocycles and pretty flexible polymethine groups. Many 
cyanine dyes are relatively non-toxic, have modifiable structures and intense molar 
absorptivities. The cyanine dyes that are excellent fluorescent molecules are widely being 
Figure 17 Generic cyanine dye (left), symmetrical cyanine dye (middle), and 
asymmetrical cyanine dye (right). 
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synthesized and patented. These molecules are cost-efficient and handy to work with, that makes 
their wide utilization in biomolecular labeling. Cy3 and Cy5 dyes are also being used as 
conjugates with peptides and oligonucleotides to target the specific diagnostic receptor.42,43 
1.8 Cyanine dyes as a potential therapeutic agents 
In a review paper published by Shi and coworkers, the authors talked about the potential of 
cyanine dyes as theranostic agents, molecules that can be used for therapeutic and diagnostic 
purpose simultaneously. They presented a series of heptamethine cyanine dyes and their 
interactions with cancer cells, focusing on selective accumulation, retention time and cell 
organelles uptake. IR-808 was tested on tumor cell lines including the human lung cancer cell 
line A549, NCIH-460.44  
 
 
 
 
 
 
 
 
Luo and coworkers used rat dermal stem cell-derived sarcoma cells (rTDMCs) to test the 
in vitro cytotoxicity of IR-808DB, n-butyl ester derivative of IR-808. Cells were incubated with 
2.5 μM of IR-808 under dark conditions at 37 °C for 24 h. After that, cells were exposed to 808 
nm light (200 mw/cm2) for 5 min and then again incubated for 24 h in dark. When the cell 
viability was tested, it was found that significantly low optical density was observed as compared 
Figure 18 Structures of NIR cyanine dyes. 
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to dark controls.44  Similarly, IR-783 was studied using prostate cancer cell lines such as PC-3, 
LNCap, DU-145, etc. by using 780 nm light.45 IR-780 was studied with human breast cancer cell 
lines MCF-7, MDA231.46 MHI-148 was experimented with human prostate cancer cell lines PC-
3, LNCap, C42. 45 In all cases, the drugs under investigation preferentially accumulated in tumor 
cells and had no cytotoxicity in normal cells. All of these compounds were reported to absorb 
light in the phototherapeutic window (700 nm – 900 nm). They were reported to be stable in 
water. 
 
 
 
 
 
Cellular uptake studies on all of the heptamethine dyes shown in Fig. 18 showed that they 
either accumulated in mitochondria or lysosomes. Many NIR cyanine dyes have properties such 
as easily modifiable structures to achieve pharmacological goals, high permeability across the 
cellular membranes, and cost efficiency in synthesis and purification. Due to these properties, 
their importance in PDT is increased and widely considered in terms of achieving ideal 
phototherapeutic drugs. Recently, scientists synthesized drug-dye conjugate to increase the 
action and /or specificity of dyes into the diseased cell lines. Zhang et al. synthesized IR-780 
conjugated with nitrogen mustard47 and Wu et al. synthesized MHI-148 conjugated with 
clorgyline, a monoamine oxidase inhibitor A48 that can target human prostate cancer cell lines. 
Moreover, It was reported that IR-783 conjugated with gemcitabine was capable of delivering a 
Figure 19 Cyanine dye-drug conjugates. 
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drug into the brain tumors of mice. All of these findings further enhance the potential of using 
cyanine dyes as PDT agents. 
NIR heptamethine cyanine dyes are believed to enter into cells through an active ATP 
driven transport system that involves organic anion-transport polypeptides (OATPs). OATPs are 
membrane-bound solute carriers that have enhanced expression in tumor cells as compared to 
normal cells, and they mediate in transporting amphiphilic compounds inside cells. The purposed 
mechanism of the intake of cyanine dyes is presented in Fig 20. When hypoxic conditions result 
in HIF1α protein overexpression, this triggers the transcription of OATP genes resulting in the 
large production of OATPs. Once the OATPs are produced inside the cell, they exit the Golgi 
complex and bind to the plasma membrane. In addition to this mechanism, other mechanisms of 
cyanine dye transport inside the cells have been proposed, including the involvement of low-
density lipoprotein receptors. The mitochondrial accumulation of the cyanine dyes is believed to 
be linked with the signaling by a mitochondrial membrane-bound molecule called sulfane sulfur. 
Mitochondria are the main production house of cellular ROS, and it is believed that sulfane 
sulfur can be produced as a result of a reaction between H2S and ROS inside the mitochondria.
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Figure 20 A schematic outline of the molecular mechanisms underlying the specific 
uptake of NIRF dyes by normal cells, which is coordinately mediated by tumor 
hypoxia, a HIF1α/OATP signaling axis and mitochondrial membrane potential. 
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Although cyanine dyes appear to have great potential for use in the PDT, there are several 
challenges ahead to optimize all the factors that are involved in PDT theranostics to make 
cyanine molecule available in the drug market. Stability and solubility under physiological 
conditions are still major issues. Amphiphilicity still remains an important consideration 
regarding the transport and retention of dyes inside the cells, and need to be addressed. 
Absorbance of long wavelength NIR light by PS and the production of reactive oxygen species 
in the phototherapeutic window is another major factor contributing to the complete remission of 
tumors. Drugs sensitivity towards diseased infected tissue should also be considered. In addition, 
pharmacokinetics, pharmacodynamics, and toxicology study need to be conducted in larger 
animal models such as dogs or pigs rather than relying only upon small animals such as mice, to 
increase the reliability and effectiveness of cyanine molecules in PDT for human use.  
In recent studies, several papers have been published regarding the structural 
modifications of cyanine dyes in order to optimize their therapeutic properties. B. Ciubini et al. 
reported the synthesis of heteroatomic benzoindolenine ring pentamethine cyanine dyes with 
electron withdrawing group substitution on a ring or the pentamethine meso position.50 They 
claimed that bromine substituted cyanine dyes have a slightly higher rate of ROS production but 
not significant. All of the studied dyes were reported to have absorption maxima around 680-690 
nm. Another paper published in 2017 showed that iodinated IR-783, a cyanine dye, has enhanced 
phototoxicity due to the enhancement of production of singlet oxygen as compared to its non-
iodinated counterpart. They used mice bearing BxPC-3 pancreatic tumors to document the 
effects of iodinated IR-783.51 A paper published by Pandey et al. tried to study light dosimetry 
and its effect on dye photobleaching and degradation by taking consideration of NIR cyanine 
dyes and their conjugates.52 According to these authors, a semi quantitative relationship exist 
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between photobleaching of sensitizer and photodynamic efficacy. Furthermore, synthesis of 
some unsymmetrical squarylium cyanine dyes derived from benzothiazole and quinolone was 
reported and also their phototoxicity was screened against HepG2 and Caco-2 cells.53 The 
compounds under investigations were phototoxic when exposed to 630 nm laser light. In addition 
to these papers, several studies were recently published investigating the cyanine dyes properties 
with a goal of utilizing them in PDT. 
In this research project, we are trying to optimize the phototherapeutic properties of 
cyanine dyes by taking into consideration several factors in order to achieve an ideal 
photosensitizer. A series of pentamethine phenanthridinium cyanine dyes were chosen to test 
near infrared DNA photocleavage and fluorescence capabilities. A pentamethine bridge was 
selected to achieve long wavelength light absorption. The phenanthridinium system was chosen 
as the ring system to afford substantial DNA affinity, similar to the known phenanthridinium 
intercalator ethidium bromide. Electron withdrawing atoms were introduced to stabilize the dyes 
from photobleaching and degradation in aqueous solution. 
 
 
 
 
 
 
 
 
Figure 21 structures of pentamethine phenanthridinium cyanine 
dyes studied in this project. 
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1.9 Purpose of the Study 
The goal of the project is to contribute in developing candidate DNA photosensitizers 
that can be activated by near-IR light and used in photodynamic therapy. For this purpose, we 
first scanned a series of carbocyanine dyes using spectroscopic techniques to understand the 
structure-stability relationship in aqueous and organic solutions. Then, we studied the interaction 
and binding properties of cyanine dyes with duplex DNA. Once we understood molecular 
interactions and behaviors of cyanine dyes in presence and absence of DNA, we focused our 
research on cyanine dye–sensitized photocleavage reactions. A detailed mechanistic and kinetics 
study of DNA photocleavage was conducted. In the later part of the project, we focused our 
study on identifying reactive oxygen species involved in photocleavage reactions. Finally, we 
attempted to provide information towards the design of next generation cyanine dyes with 
enhanced DNA photosensitizing properties. 
1.10 Specific aim and expected results 
Specific Aim 1: Study the photocleavage of DNA over near-infrared wavelengths 
(700 nm to 905 nm). 
We have discussed about different types of synthetic photo nuclease compounds in our 
introduction section. Metalized photo nucleases are found to cleave DNA in the phototherapeutic 
window, which lies between 700 nm to 915 nm; however, the metalized complexes have high 
dark toxicity and low molar absorptivity. As an alternative, our goal is to optimize less toxic, and 
strongly absorbing near-infrared cyanine dyes that can photocleave the DNA. Near-infrared 
wavelength is of particular importance because in this range light can penetrate deeply into the 
tissue, potentially rendering photo therapy effective even in highly dense tumor tissue. 
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Specific Aim 2: Study the mechanisms and possible species involving in cyanine dyes 
sensitized DNA photocleavage 
Reactive oxygen species are generated during photo nuclease reactions that damage the 
DNA. In a type I reaction, the excited triplet state sensitizer (3PS*) transfers electron to the 
ground state triplet oxygen (3O2) to produce superoxide anion radicals (O2
-•) which then 
spontaneously forms H2O2 through dismutation. The H2O2 then produces hydroxyl radicals 
(•OH) through iron(II) or copper(I) catalyzed Fenton chemistry (Scheme 2 and 3). In Type II 
photosensitization process, singlet oxygen (1O2) is formed upon energy transfer from 
3PS* to 
3O2. 
12,17,18 
3PS* + 3O2 → 
3PS*+ + O2
•- 
Fe3+ + O2
-• → Fe2+ + 3O2 
2O2
-• + 2H+ → H2O2 + 
3O2 
Fe2+ + H2O2 → Fe
3+ + •OH + OH- 
Scheme 2 Mechanism of ROS generation 
3PS* + Cu2+ → 3PS* + Cu+ 
Cu+ + 3O2 → Cu
2+ + O2
-• 
2O2
-• + 2H+ → H2O2 + 
3O2 
Cu+ + H2O2 → Cu
2+ + •OH + OH-  
Scheme 3 Mechanism of ROS generation 
Our second goal is to find out which reactive species ((•OH and/or 1O2) are involved and 
what could be the possible cleavage mechanism. 
Specific Aim 3: Study the fluorescence emission of the compounds to consider 
possible applications in biomolecule labeling 
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Indocyanine green, and Cy series of cyanine dyes (Fig 22) are known to be used in 
biomolecule labeling.15’42 Some of the cyanine dyes such as indocyanine green can absorb light 
above 700 nm; at this wavelength, the light penetration is deep through tissues. 
 
 
 
 
 
 
 
Cyanine dyes such as Cy3, Cy5 are highly fluorescence because of their high quantum 
yield and high photon absorptivities. They can be modified with an activated ester that can target 
and then covalently link to specific biomolecules. In a quest to evaluate the potentiality of 
labelling DNA and other biomolecules, cyanine dyes that are being investigated in this project 
will be tested for their fluorescence properties. 
Specific Aim 4: Study the DNA binding modes and their relation to DNA 
photocleavage 
Intercalative vs. non-intercalative interactions can be predicted with some degree of 
certainty by doing UV-visible absorption, fluorescence, and circular dichroism experiments.  
Circular dichroism (CD) analysis of cyanine dyes can be used to further solidify the 
evidence of a specific type of DNA interaction. Upon binding to duplex DNA, if an induced CD 
(ICD) with a bisignate peak is produced, it suggests dimeric or higher order binding in one of the 
DNA grooves. A weak positive or negative peak indicates monomeric groove binding. A large 
Figure 22 some examples of fluorescent cyanine. 
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positive and small negative peak or vice versa suggests intercalation.54 Besides, we can compare 
CD patterns when a compound is mixed with duplex oligonucleotides of various compositions, 
e.g. [Poly (dG-dC)]2 vs. [Poly (dI-dC)]2. Let us say, if there is a strong ICD peak in case of [Poly 
(dI-dC)]2 as compared to [Poly (dG-dC)]2, this suggest that the compound prefers minor groove 
binding because [Poly (dI-dC)]2 has less interference in its minor groove as compared to its 
counterpart [Poly (dG-dC)]2.
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Competitive displacement by a well-known DNA binder might provide information about 
the binding modes of the dyes under study. The spectral changes in the DNA sample that 
contains a saturating concentration of dye with a saturating concentration of the well-known 
binder can be tracked and analyzed. For this purpose, a UV-visible spectrophotometer and 
fluorescence microplate reader can be used.56,57,58 Furthermore, we can employ some well-
known minor groove binder or intercalator to alter the photocleavage efficiency of the dye by 
competing for its binding site and use this information to predict the DNA binding mode of the 
dye. The binding affinities of a compound with AT-rich, GC-rich, and mixed sequence calf 
thymus (CT) linear DNA can also be studied through gel shift assays and UV-visible 
spectrophotometry. 
DNA binding mode can affect the fluorescence yield tremendously. Binding of dye 
molecules between the DNA base pairs (intercalation) conformationally restrict the twisting 
motion of the molecule. In addition to the restriction, intercalation also prevents the interaction 
of molecules with the surrounding solvent molecules resulting in the blockage of non-radiative 
decay. As a result, a fluorescent molecule shows higher fluorescent emission when it intercalates 
between DNA base pairs as compared to DNA groove binding or external binding.2  
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In addition to the above methods, a NMR spectrophotometer can be used to analyze the 
chemical shifts of the protons of DNA base pairs. For example, the chemical shift of the imino 
protons of DNA base pairs in DNA major and minor grooves provides valuable information 
regarding the binding mode of the compound.59 
Specific Aim 5: Study the effect of the structural modification on the compound 
stability and binding affinity 
The stability of dyes in the presence and absence of DNA will be studied. Structural 
modifications of the dyes were made to enhance the stability and efficiency of photocleavage 
(Fig 18). Dye 1 was substituted in the meso position by a chlorine (dye 2) and a bromine (dye 3) 
atom to synthesize dye 2 and 3. Similarly, dye 4 was synthesized by substituting two ring 
hydrogens by two bromine atoms.  
The binding affinity of the cyanine dyes can be studied by performing UV-visible 
equilibrium titrations. By taking the isosbestic point as a reference, the disappearance of the 
reactant or formation of the product can be taken into consideration for the calculation of binding 
constant in an equilibrium reaction for the formation of a DNA cyanine dye complex.  
[DNA] + [Dye]   [DNA-Dye] 
The correlation among the binding affinity of a dye to DNA, the stability of a dye in the 
presence and absence of DNA, and efficiency of photocleavage can be compared. The obtained 
information should be important in designing future generation NIR photo nucleases.  
Other than above mentioned experiments, the kinetics of DNA photocleavage will be 
studied by running time course reactions. One can potentially use this information for future drug 
design. 
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2 METHODOLOGY AND EXPERIMENTAL PROCEDURE 
2.1 Materials 
All the cyanine dyes were synthesized by Maged Henary and co-workers at Georgia State 
University. They were used without further purifications. Spectrophotometric grade dimethyl 
sulfoxide (DMSO), 99.9% was purchased from Sigma-Aldrich. Molecular biology grade agarose 
was from Sigma Life Science, ethidium bromide was bought from Sigma, agarose gel loading 
buffer was prepared by using ficoll and bromophenol blue in deionized water. CT-DNA was 
purchased from Invitrogen. pUC19 DNA was cloned by using E. coli Strategene competent cells 
according to a  standard laboratory protocol.60 Plasmid DNA was purified by using Qiagen 
Plasmid Maxi Kit. LED lights 780 nm (200 mW/cm2), 830 nm (350 mW/cm2), 850 nm (100 
mW/cm2), and 905 nm (50 mW/cm2) were purchased from Civil Laser Civil Light Source 
Supplier and Laserland® Store. sodium phosphate dibasic salt, sodium phosphate monobasic salt, 
and ethylenediaminetetraacetic acid disodium salt (EDTA-Na2) were purchased from Fisher 
Scientific. D2O, sodium azide, sodium benzoate, and pentamidine isethionate salt were from 
Aldrich. Reactive oxygen species detecting probes p-hydroxyphenyl fluorescein (HPF) and 
singlet oxygen sensor green (SOSG) were purchased from Invitrogen. A Taq PCR kit was from 
BioLab® Inc. Ficoll® 400 and methylene blue were obtained from Fluka BioChemica. 
Oligonucleotides were from Integrated DNA Technology (IDT). An oligonucleotide desalting 
column was purchased from Sorbtech and used according to the protocol provided by the 
Company. NMR solvents D2O and d6-DMSO were purchased from Aldrich. Acrylamide (≥99%) 
and N', N'-methylene-bis-acrylamide were from Aldrich. TEMED was from USB. Methyl green 
was purchased from GTL Laboratories Supply. Bromophenol blue and hydrogen peroxide were 
purchased from Aldrich. The mother stocks of all the dyes were dissolved in spectroscopic grade 
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DMSO and stored in a -20 °C freezer. The concentrations of mother stocks were in a range of 5-
10 mM. The working sub stocks (500 mM) were also dissolved in DMSO and were stored in -4 
°C refrigerator. 
2.2 Instruments and assays 
UV-visible spectra were recorded by using Shimadzu UV-2401PC and Perkin Elmer 
Lamda 35 Spectrophotometers in a range of 200 nm to 1100 nm. Fluorescence spectra were 
recorded by using a Perkin Elmer LS55 Fluorescence Spectrophotometer. Circular dichroism 
spectra were acquired with a Jasco J-810 spectrophotometer. Gel electrophoresis was used to 
observe the percentage cleavage of supercoiled plasmid DNA, and gel pictures were taken using 
a VWR scientific Photodoc-IT Imaging System. An Eppendorf Thermocycler was used to 
amplify polymerase chain reaction products using Taq polymerase kit purchased from BioLab® 
Inc. An ethidium bromide displacement study was performed using a Fluorostar Microplate 
Reader 403-0182. Scavenging reagents such as sodium benzoate, sodium azide, catalase, and 
EDTA were used to probe for the presence of ROS in the photocleavage reaction. The reactions 
were conducted in the fume hood covered by dark foam boards to block light from outside 
sources. Singlet Oxygen Sensor Green (SOSG) and 3’-(p-hydroxyphenyl) fluorescein (HPF) 
probes were used to observe the generation of reactive oxygen species generated during the 
photocleavage reactions. Denaturing polyacrylamide gel electrophoresis (PAGE) was conducted 
followed by UV-visible shadowing to check the purity of the oligonucleotides. N-5 desalting 
columns purchased from Sorbtech were used to desalt the purchased oligonucleotides. Primers 
were designed using the tools from the NCBI website and were purchased from Integrated DNA 
Technology. NMR experiments were conducted with a 500 MHZ Bruker NMR 
spectrophotometer.  
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2.3 Procedure 
2.3.1 Concentration-dependent photocleavage experiments  
A range of concentrations of cyanine dyes was photo-reacted with 38 µM bp of pUC19 
plasmid DNA in 10 mM sodium phosphate buffer at pH 7. The samples were irradiated for 60 
min at ~ 10 ºC using a calibrated 780 nm (200 mw/cm2) laser light. The control reactions with or 
without compound were kept in the dark at room temperature for 60 min. A control reaction at 
37 ºC was irradiated with a 780 nm light without compound for an hour. A control reaction 
without compound was also kept in ~ 10 °C for an hour. A temperature of ~ 10 °C was 
maintained by mixing half ice and half water in a glass pate. A metal block with Eppendorf 
holder was placed on top of ice-water bath. The temperature of the metal block was constantly 
monitored during the reaction by placing a thermometer in the metal block. A laser light was 
then placed on the metal stand clamp and arranged in a way so that the light was just above the 
Eppendorf tube’s sample.  A temperature of 37 °C was maintained by using a heat block. 
 After the reaction was completed, a total of 2.5 µL of electrophoresis loading buffer (15.0% 
(w/v) Ficoll, 0.025% (w/v) bromophenol blue) was transferred to each 30 µL cleavage reaction. 
The samples were then loaded into 1.3% non-denaturing agarose gels stained with ethidium 
bromide (0.5 µg/mL, final concentration) and electrophoresed at ~ 100 V using 1 x TAE running 
buffer in an OWL™ mini electrophoresis system (Thermo Scientific). Gels were visualized on a 
trans- illuminator, photographed, and then quantitated with ImageQuant version 5.2 software. 
The quantitative data obtained for supercoiled DNA were multiplied by a correction factor of 
1.22 to account for the decreased binding affinity of ethidium bromide to supercoiled plasmid as 
compared to nicked and linear. Photocleavage yields were then calculated using the following 
formula: 
38 
Percent photocleavage = [(Linear + Nicked DNA)/(Linear + Nicked + 
Supercoiled DNA)] x 100 
2.3.2 Temperature-dependent photocleavage reactions 
The samples containing 38 μM bp of pUC19 DNA and 50 μM of compound in pH 7 
sodium phosphate buffer. The photoreaction was conducted in ~ 10 °C and room temperature. 
Similarly, other samples were reacted at 37 °C. The effects of heating and cooling on DNA 
photocleavage were analyzed by doing gel electrophoresis of the samples similar to the 
procedure explained in the previous section.  
2.3.3 Wavelength-dependent photocleavage experiments 
The calibrated laser lights of 660 nm, 700 nm, 730 nm, 750 nm, 780 nm, and 850 nm 
were used for DNA photocleavage. The cleavage percentage at each wavelength was calculated. 
The longest possible wavelength which has relatively good percentage of cleavage was then 
determined. Each sample containing 50 μM of compound with 38 μM bp of pUC19 DNA was 
prepared in 10 mM sodium phosphate buffer of pH 7.  The samples were irradiated for 60 min at 
~ 10 ºC. The quantitative analysis was done by using the gel electrophoresis technique described 
in section 3.3.1 
2.3.4 Time-dependent photocleavage 
A number of samples containing 50 µM of a compound were mixed with 38 µM bp of 
pUC19 DNA in 10 mM sodium phosphate pH 7.0 buffer and irradiated at various time points up 
to 2 h at ~ 10 ºC. Each time point reaction mixture was then analyzed using agarose gel 
electrophoresis. A plot was made consisting of percent cleavage as a function of time to find the 
apparent halftime of each photocleavage reaction.  
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2.3.5 UV-visible experiments to test dye stability 
A UV-visible spectrophotometer was used to measure absorption of the 20 μM dyes 
overtime to test for dye stability in different solvents. The spectra were recorded for different 
concentrations of dye in DMSO. The spectra were also recorded for each dye in 10 mM sodium 
phosphate pH 7.0 buffer in the absence and presence of 150 μM bp CT-DNA. The spectra were 
recorded at 5 min interval for each sample. 
2.3.6 Fluorescence experiments 
The potential for fluorescence emission was tested by using a fluorescence 
spectrophotometer. The samples prepared in pH 7 sodium phosphate buffer contained 20 μM of 
dye in the presence and absence of 150 μM bp of CT-DNA. The samples excitation wavelength 
(λexc) was selected according to the dyes’ absorption spectra. The samples were prepared in a 3 
ml quartz cuvette with a path length of 1 cm. All the experiments were conducted in room 
temperature. The excitation slit width was set to 4.5 on the Fn Win Lab software. Samples 
containing 5 μM ethidium bromide and 10 mM sodium phosphate buffer pH 7.0 in the presence 
and absence of 100 μM CT-DNA were used as controls for this experiment.  
2.3.7 DNA binding affinity experiments 
A series of UV-visible titrations were done by adding calf thymus DNA in increasing 
amounts to a fixed amount of each dye. The samples contained 25 μM of dye in 10 mM sodium 
phosphate pH 7.0. Each time after addition of CT-DNA, spectra were continuously recorded 
until there was no change in absorbance. The 2500 and 5000 μM bp of CT-DNA stock solutions 
were prepared in 10 mM sodium phosphate pH 7 buffer. For the first 12 readings, each time 1 μL 
of 2500 μM bp of CT-DNA was added and the spectra were recorded, followed by 1 μL of 5000 
μM base pair of CT-DNA per reading until the concentration reached a saturation point in which 
40 
dye absorption no longer changed upon DNA addition. Association constants were calculated by 
making a linear plot as shown by Meehan et al.61 The decrease in absorbance of the free drug 
peak represents the disappearance of free drug and formation of a complex in titration spectra. 
The absorbance at which there was no DNA gave the value of Ɛf. The absorbance for the other 
drug-DNA ratios gave the value of Ɛa for that drug-DNA ratio. Once the values of Ɛf and Ɛa were 
calculated from the spectra, then a linear plot was made by keeping the values of [DNA]/( Ɛa - Ɛf 
) as Y-ordinate and [DNA] as X-ordinate. The linear fit of the data was made, and the values of 
slope and intercept were computed from the generated equation of the linear line.62 When the 
values of slope and intercept were obtained, a ratio of slope and intercept gave the value of 
binding affinity Kb. 
2.3.8 Polymerase chain reaction and gel shift experiments 
The high GC content and AT content fragments of pUC19 DNA were amplified using 
polymerase chain reactions. The targeted fragment for the AT-rich segment of pUC19 DNA was 
started from the 1720th base pair and ended at the 1882th base pair on the pUC19 sequence 
obtained from the NCBI website (https://www.ncbi.nlm.nih.gov/nuccore/M77789.2). The 66% 
AT-rich fragment (163 base pairs) was amplified by using a forward primer (5’-
gtgcctcactgattaagcat-3’) and reverse primer (5'-gctcagtggaacgaaaactc-3'). Similarly, a targeted 
162 fragment for the 58% GC rich sequence was started from the 2271th base pair and ended at 
the 2432 base pairs on the pUC19 sequence. The forward and reverse primers for a targeted 162 
bp GC rich sequence were 5’-acgacctacaccgaactgag-3’ and 5’-aggactataaagataccaggcgt-3’.  
The PCR reactions were conducted in an Eppendorf AG 6325 thermocycler. The samples 
contained standard Taq reaction buffer (1X), dNTP 200 μM, upstream primer 0.2 μM, 
downstream primer 0.2 μM, Taq DNA polymerase 1.25 unit/μL, and pUC19 DNA 0.023 μM bp 
41 
in DI water. The total volume in each sample was 50 μl. Stock solutions consisted of standard 
Taq reaction buffer (10X), dNTP 10 mM, upstream primer 26.7 μM bp, downstream primer 31.7 
μM bp, Taq DNA polymerase 5000 unit/ml, and pUC19 DNA 1 μM bp. 
The timing of a thermal cycle for denaturation, annealing, and extension was adjusted to 
obtain the highest concentration of amplified DNA. The initial denaturation was done at 95 °C 
for 30 s. Then, denaturation at 95 °C for 30 s, annealing at 55 °C for 60 s, extension at 68 °C for 
60 s was repeated for 30 cycles. The final extension was conducted at 72 °C for 5 min. The same 
conditions were employed for both fragments amplification. The obtained amplified DNA was 
then used in gel shift and fluorescence microplate displacement experiments. The gel shift 
samples contained 40 μM bp of AT or GC rich DNA fragment with 50 μM of dye in sodium 
phosphate buffer of pH 7. The samples were then loaded in a 2.0 % agarose gel and 
electrophoresed for 2 h at 230 V in a Thermo Scientific OWL A1 gel electrophoresis gel box. 
The 1X TAE buffer was used as a running buffer. After the electrophoresis, the gel was stained 
with 0.5 μg/mL ethidium bromide and visualized using the PhoDoc-Ittm 60 Imaging System.  
2.3.9 Circular dichroism experiments 
Circular dichroism was used to further probe dye binding modes with DNA. The samples 
contained saturated dye (20 μM) to CT-DNA (150 μM bp) ratio in 10 mM sodium phosphate 
buffer of pH 7. Then 2000 μL of each sample was transferred into a 1 cm path length quartz 
cuvette of 3000 μL capacity. The CD and ICD spectra were recorded using an IR extender in 
Jasco-810 CD spectrophotometer. The parameters used were: high sensitivity, 100 nm/min scan 
speed, 2 s response time, and 0.5 mm pitch. For each sample, 12 acquisitions were recorded at 
room temperature and then averaged. 
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2.3.10 Fluorescence microplate reader experiments 
The samples were prepared in 96 well Corning 25880 flat bottom white plates. A Fluostar 
microplate reader was used to record the change in emission with the gradual increase in the 
concentration of ethidium bromide. The excitation wavelength was 485 nm and the emission 
wavelength was set to 520 nm. The samples final concentrations were 20 μM base pair of CT-
DNA and 25 μM of dye in 10 mM sodium phosphate buffer of pH 7 and were equilibrated for 
five minutes. After the equilibration, gradual increments in ethidium bromide (0, 5, 10, 20, 30, 
40, and 50 μM final concentrations) were added in each sample and again equilibrated for 5 min 
before the recording. The emission gain of the instrument was adjusted by using blank sample 
which contained 10 mM of pH 7 sodium phosphate buffer and a standard sample which 
contained 50 μM of ethidium bromide, 20 μM bp of DNA, and 10 mM sodium phosphate buffer 
of pH 7. The sample volume in each well was 100 μL. The stock solutions were 100 mM sodium 
phosphate buffer of pH 7, ethidium bromide 500 μM in DI water, dye 500 μM in DMSO, and 
DNA 500 μM bp in 10 mM sodium phosphate buffer of pH 7. The emission was recorded for 
each well, and a plot was made for the emission of each sample as a function of ethidium 
bromide concentration.  
2.3.11 UV-visible displacement experiments 
The UV-Visible displacement assays were prepared by using a well-known major groove 
binder methyl green, minor groove binder pentamidine, and intercalator ethidium bromide. The 
samples contained saturated concentration of dye (20 μM) with CT-DNA (100 μM bp) in 10 mM 
pH 7 sodium phosphate buffer. Then, a gradual increase in the concentration of a binder was 
added (starting from 0 up to 100 μM of binder final concentration). A spectrum was recorded 
after each addition. The recording was continued until there was 2:1 binder to DNA ratio in the 
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sample. The displacement study was conducted by preparing the sample by adding the reagents 
in the order of DNA-dye- binder and DNA-binder-dye.  The change in spectral pattern according 
to the reagents addition order was compared. 
2.3.12 Competitive binding mode experiments 
Photocleavage experiments were conducted using a well-known groove binder or 
intercalator. Each sample contained 50 μM of dye and 40 μM bp of pUC19 DNA in pH 7 sodium 
phosphate buffer. After the 5 min equilibration of dye and DNA, the well-known binder was 
added so that the binder’s final concentration was 50 μM. The total volume of the sample was 30 
μl. Methyl green was used as a major groove binder. Freshly prepared pentamidine was used as a 
minor groove binder. Ethidium bromide was used as an intercalator. All the stock solutions of 
binders were prepared in 10 mM pH 7 sodium phosphate buffer and ranged in concentration 
from 5-10 mM. All the stock solutions were stored in + 4 °C refrigerator.  The samples were then 
irradiated with 780 nm LED laser light (200 mw/cm2) for an hour at ~ 10 °C in a dark chamber. 
After the completion of the reactions, samples were analyzed on a 1.3% agarose gel.  
2.3.13 Scavenging experiments 
ROS scavenging reagents were used to detect reactive oxygen species involved in the 
photocleavage reactions. Sodium azide was used as a singlet oxygen scavenger. Similarly, 
sodium benzoate was used as a hydroxyl radical scavenger, catalase was employed as a hydrogen 
peroxide scavenger, EDTA was used as a chelating agent that can prevent Fe(II)-catalyzed 
Fenton chemistry. D2O was used as a solvent instead of H2O as it is expected to enhance the 
percent photocleavage if singlet oxygen is involved in a photocleavage reaction, as D2O 
increases the life time of the 1O2. The samples contained 50 μM of dye and 38 μM of pUC19 
DNA with or without 100 mM of sodium azide, 100 mM of sodium benzoate, 100 mM of 
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EDTA, or 2.5 unit/μl of catalaze. In case of D2O samples, the water was replaced by D2O. The 
percentage (v/v) of D2O in the D2O sample was 82 %.  Photocleavage reactions were conducted 
in 10 mM sodium phosphate buffer of pH 7 at ~ 10 °C for 60 min. The percentage of 
photocleavage inhibition was calculated by using the following formula: 
% inhibition = {(percent nicked + linear in presence of scavenger) – (percent nicked + linear in 
absence of scavenger)}/ (percent nicked + linear in absence of scavenger) 
2.3.14 ROS detection experiments 
ROS probes HPF and SOSG were used to detect the ROS generated during a 
photoreaction. The mother stock of SOSG (1.25 mM) was prepared in methanol, and the mother 
stock of HPF (5 mM) was prepared in DMF. The mother stocks were stored in - 20 °C. HPF can 
detect both singlet oxygen and hydroxyl radicals, while SOSG selectively detects the presence of 
singlet oxygen in a sample. Methylene blue was used as a positive control as it generates singlet 
oxygen when irradiated with 638 nm light. Fenton reagent ((Fe(NH4)2(SO4)2 (10 μM)  + H2O2 
(10 μM)) was used as a positive control for the production of hydroxyl radicals. Sodium 
benzoate (100 mM final concentration) was used to scavenge the hydroxyl radicals. Each 
samples contained 20 μM of a compound and 10 mM pH 7 sodium phosphate buffer. Then, HPF 
was added to make the final HPF concentration 3 μM, and the samples were irradiated by 780 
nm light for 15 min in room temperature. In the case of SOSG, the final concentration of probe 
was 0.75 μM, and the samples were irradiated with 780 nm light for 15 min at room temperature. 
After the completion of a photoreaction, the samples were analyzed with a fluorescence 
spectrophotometer. The excitation wavelengths for HPF and SOSG were 490 nm and 480 nm, 
respectively. The emission spectra of samples were compared with the positive and negative 
control reactions. 
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2.3.15 NMR experiments 
Oligonucleotides were purchased from Integrated DNA Technology (IDT). The 
oligonucleotides were then desalted using N5 desalting columns purchased form Sorbtech 
Technology. The purity of the oligonucleotides was checked by UV shadowing 15 % 
polyacrylamide gels.  
 Various stock solutions consisted of 40 % acrylamide mixed with 2 % bis acrylamide, 10 
% ammonium persulfate, and 2X formamide loading buffer. The protocol was followed from the 
Molecular Cloning Laboratory Manual, second edition, volume 1.60 A 2X loading buffer was 
prepared which contained 90 % formamide, 0.5 % bromophenol blue, and 2X TBE buffer. The 
concentration of the oligonucleotide in the sample was 100 μM and was prepared in 10 mM pH 7 
sodium phosphate buffer. The total volume of the sample was 30 μL. Before loading, the sample 
was mixed with 20 μL of 2X loading buffer then 20 μL of sample was loaded in each well on the 
gel.  
A 15% acrylamide gel was prepared by mixing 5.6 mL of 40 % acrylamide, 7.22 g of 
urea, 3 mL of 10X TBE buffer, and 1 mL of DI water. Once, the 15 % gel solution was ready, 
7.5 μL of ultrapure TEMED and 50 μL of 10 % of ammonium persulfate (APS) solutions were 
added. Immediately after the addition of TEMED and APS, the solution was poured into the gel 
plates and was waited for an hour to complete the gel casting. Once the gel was set, the sample 
was loaded and electrophoresis was conducted using Mini-PROTEAN® II Electrophoresis Cell. 
The setup was done according to the manual provided by the BIORAD for Mini-PROTEAN® II 
Electrophoresis Cell. The gel was electrophoresed for 90 min using 1X TBE buffer and a voltage 
of ~150V.  
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After the electrophoresis was completed, the purity of the oligonucleotide was observed 
by using UV light. The gel was carefully taken out from the electrophoresis plate, lined with 
Saran wrap, and then placed on top of a TLC Silica gel 60 F254 plate. The TLC plates were 
purchased from EMD Chemical Inc. The sizes of the plates were 5 * 7.5 cm. The picture of the 
gel was taken by activating the TLC plate with a 366 nm UV light.  
The chemical shift of oligonucleotide imino proton in a range of 10 to 14 ppm was 
compared in the presence and absence of dye. A sample containing 100 μM of oligonucleotide 
was prepared in 90% H2O and 10% D2O that contained 10 mM sodium phosphate, 20 mM NaCl, 
and 0.5 mM EDTA. The spectra were recorded for a range of dye concentrations starting from 0 
to 200 μM. The pH of the final sample was adjusted to 6.78 by using NaOH or HCl. The sample 
was analyzed in a 500 MHZ Bruker NMR spectrometer. All the spectra were recorded in 298 K.  
A NOESY experiment was conducted in 100% D2O. The oligonucleotide, phosphate 
buffer, NaCl, and EDTA concentrations in the sample were 100 mM, 10 mM, 20 mM, and 0.5 
mM respectively. The final pD was 6.49. The chemical shifts of the base pair protons at the 
different dye-oligonucleotide ratio (from 0.25/1 to 3/1) were compared. 
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3 RESULTS AND DISCUSSIONS 
3.1 Stability test in water and DMSO in the presence and absence of DNA 
3.1.1 In DMSO 
Cyanine dyes’ photo physical and photochemical stability play important roles, when 
they are investigated as potential drug candidates. They tend to aggregate under physiological 
conditions which might affect their fluorescent quantum yields. Their photo bleaching and 
stability in aqueous solutions depend on their structure and the presence of reactive oxygen 
species in the solution.63 Electron withdrawing substituents can reduce the oxidation potential of 
a dye, stabilizing it against autoxidation in solution. Assembly of a cyanine dye through 
noncovalent interactions in the presence and absence of nucleic acid can be studied using a UV-
visible spectrophotometer. The characteristic dye absorption peaks in a given solvent in presence 
and absence of DNA provide valuable information about dye interactions and aggregation 
patterns. Depending upon the type of cyanine-DNA interactions and the solubility of dye under 
physiological conditions, the potential of cyanine dye as a phototherapeutic and fluorescent agent 
can be assessed. Amphiphilic dyes are considered as ideal phototherapeutic agents as they can 
easily pass through cell membranes. Generally, DNA intercalated cyanine dyes show higher 
fluorescence as compared to groove or external binders. This has been proposed to be due to the 
restriction of the dye molecules with respect to their conformational rotation and interactions 
when they are intercalated in DNA base pairs.2  
Absorption wavelength and the molar absorptivity of a cyanine dye are two important 
factors that play vital roles in achieving an ideal DNA photosensitizer. Cyanine dyes can 
aggregate in aqueous solution in presence and absence of DNA. If a cyanine dye is soluble in a 
solvent and does not aggregate, it exists as a monomer, and a single sharp peak can be seen in a 
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UV-visible spectrum. If multiple peaks are seen, then there might be aggregation. If the 
absorption peak is seen blue shifted from the monomeric peak, it is called H-aggregation. If the 
absorption peak is seen red-shifted from the monomeric peak, then it is called J-aggregation. H-
aggregation occurs when the offset between adjacent monomers is small, and the monomers are 
face to face to form a dimer. J-aggregation occurs when the offset between the two monomers 
are large, and the monomers are stacked on end to end fashion.64,65 
 
 
 
 
 
 
Solvents of different dielectric constants can be used to study the aggregation patterns. In 
this experiment, DMSO whose dielectric constant is 47.00 and water whose dielectric constant is 
78.54 were used to test dye solubility and stability. Since the cyanine dyes under investigation in 
this chapter (Fig 23) have heterocyclic rings with a positive charge connected by a methine 
bridge; we expect that they are soluble in water and organic solvents such as DMSO. Since 
DMSO has a boiling point 189 °C, amphiphilic in solubility, and lack of dissolved oxygen, we 
can expect that the cyanine dyes (Fig 23) can be stored in DMSO for a longer amount of time. 
Time course absorption spectra of four pentamethine cyanine dyes were recorded as a 
function of time in DMSO (Fig 24). Armitage and coworkers compared the photo stability, 
molar absorptivity and aggregation pattern of a cyanine dye and its fluorine derivative. They 
found that the slight red shift in absorption peak and higher molar absorptivity in case of 
Figure 23 Structures of the dyes under investigation. 
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unsubstituted dye as compared to its fluoro-substituted counterpart. Further, they found that 
substitution increased the photo stability and increased the solubility of the dye in aqueous 
buffer.63 In this research project, we have worked with dye 1 (unsubstituted dye), dyes 2 and 3 
(substitution of dye 1 by chlorine and bromine atom in meso position of methine bridge 
respectively), and dye 4, which has substitution in heterocyclic rings by two bromine atoms (Fig. 
23). The molar absorptivity of dye 1 is found to be higher than the molar absorptivity of dyes 2, 
3, and 4. Further, the slight blue shift in absorbance in case of dyes 2, 3, and 4 in DMSO was 
seen as compared to the absorption spectra of dye 1 (Fig. 24). These findings are consistent with 
the previous findings of Armitage and co-workers, when they compared their halogen substituted 
dye with its unsubstituted counterpart.66 
 
 
 
 
 
 
 
 
 
 
 
 
The DMSO time course recordings of UV-visible spectra in Fig 24 show that all the dyes 
Figure 24 Time course UV-visible spectra of 10 μM of dye in DMSO. Spectra were 
recorded at 5 min time intervals. 
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appear to be stable in DMSO as a function of time. Although in case of dyes 1, 2, and 4, there is 
a slight decrease in absorbance in the region of 600 – 800 nm, the increase in absorbance was 
observed in 400 nm regions. This suggests that the dyes were stable in DMSO and that the 
observed absorption changes were most likely attributable to dye aggregation and not 
autoxidation. In addition to that, the two red shifted absorption peaks suggests that there are one 
or more species that are monomeric and/or lower order aggregates in the DMSO. Normally, if 
the adjacent monomers remain too close then splitting of the peak can be observed due to 
localization of the electrons among the adjacent monomers.67 
3.1.2 In aqueous buffer 
Time course spectra of the dyes in pH 7.0 sodium phosphate buffer were recorded by 
using UV-visible spectrophotometer. The stability of the dye in the aqueous buffer is expected to 
depend on the interaction of the dye with dissolved oxygen with the possibility that through 
Fenton chemistry trace metal ions might generate hydroxyl radicals (•OH) that degrade the dye. 
Most of the cyanine dyes are prone to photo bleach due to their potential to transfer energy 
and/or electrons to species present in the solution when they are irradiated by light. The dye 1 is 
expected to be less stable as compared to the other three due to lack of electron withdrawing 
substituent. Also, since dye 1 does not have any electron withdrawing group, the dye 1 is 
expected to aggregate readily as compared to other dyes.66  
In Fig 25, A dye 1 has a big decrease in absorption as a function of time suggesting that 
the dye is degrading quickly in the aqueous buffer. Thus, any assumption or reasoning about the 
aggregation of dye in water cannot be valid. But, in case of dye 2, 3 and 4, the time course 
absorption spectra show relatively higher stability as compared to dye 1. The spectra therefore 
suggest that the stability of the cyanine dyes can be increased by adding electron withdrawing 
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groups. In addition to that, if you look at the spectra of the dyes, dye 2 has two peaks. The peak 
on the left-hand side may be due to the aggregation of the molecules in aqueous solution, 
possibly H-aggregation, and that the peak in the right-hand side may be a monomeric peak. In 
dye 4, only one peak is seen. This could be because of the enhanced solubility of the dye 4 due to 
the presence of two bromine atoms.66 The relative stability of dyes in water is dye 2 ~ dye 3 ~ 
dye 4 > dye 1. 
 
 
 
 
 
 
 
 
 
 
 
 
Similarly, time course spectra of the dyes in the presence of CT- DNA were recorded in 
10 mM sodium phosphate pH 7 buffer. Dye 1 was still unstable, while dyes 2, 3, and 4 were 
relatively stable in the presence of DNA (Fig 26). Some cyanine dyes that are unstable in 
aqueous were found to be stabilized by biomolecules such as proteins and DNA because of the 
hydrophobic effect between the dye and the biomolecule.68,66 Furthermore, Armitage and co-
Figure 25 Time course UV-visible spectra of 10 μM of dye in 10 mM Na2PO4 buffer of 
pH 7. Spectra were recorded at intervals of 5 min. 
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workers studied the DNA templated helical cyanine dye aggregation in the DNA minor groove. 
According to them, the type of cyanine dye aggregation in presence and absence of DNA 
depends on several factors: steric effects, repulsive effects between substituted dye monomers, 
the type of heterocyclic ring, the length of polymethine bridge, the net charge of the molecule, 
and properties of N-substituents. They also reported that H-aggregation shows hypsochromicity 
and J-aggregation shows bathochromicity as compared to monomeric peak in absorption 
spectra.66 
 
 
 
 
 
 
 
 
 
 
 
 
 Based on the papers mentioned in previous paragraph, we can compare the dyes 
absorption spectra between DMSO and aqueous buffer. Since the dyes are soluble in DMSO, the 
dyes absorption peak in DMSO can be tentatively assigned as monomeric and/or lower order 
aggregate peaks. The two peaks in the DMSO are not due to vibrational fine structure (Fig 27), 
Figure 26 Time course UV-visible spectra of 10 μM of dye with 150 μM of CT-DNA in 10 
mM Na2PO4 buffer of pH 7. Spectra were recorded at intervals of 5 min. 
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because the ratio of the absorbance of two peaks changes as function of solvent polarity. By 
taking the peaks in DMSO as a reference peaks for monomers, we can tentatively predict 
whether the peaks in aqueous buffers are due to monomers or H or J-aggregation. If the peak is 
shifted to shorter wavelength as compared to dye’s monomeric peak in DMSO, it can be 
predicted as peaks due to H-aggregation. Similarly, if the peak is shifted to a longer wavelength, 
it can be assigned as due to J-aggregation and if the peak is approximately at the same 
wavelength, it can be assigned as a monomeric peak.66 
 
 
 
 
 
 
 
Now, let us compare the spectra of dyes in DMSO (Fig 24) and in aqueous buffer (Fig 
25). The absorption peaks for all the dyes in aqueous buffer are shifted to shorter wavelength as 
compared to the peaks in DMSO. This suggests that all the dyes are forming H-aggregation in 
aqueous buffer. Similarly, let us compare the absorption spectra of dyes in DMSO (Fig 24) and 
dye-DNA in aqueous buffer (Fig 26). Dye 1 has absorptions in same region. Dyes 2 and 3 also 
have absorptions in same region except there is a small blue shifted shoulder in buffer as 
compared to DMSO. Dye 4 has absorptions in same region except there is a major blue shifted 
peak in buffer as compared to DMSO. These observations suggest that dye 1 interacts 
monomerically with DNA. Dye 2 and 3 also interact monomerically most of the part. In contrast, 
Figure 27 UV-visible absorption spectra recorded for 20 μM 
of dye 3 as a function of amount of water in DMSO. 
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many more dye 4 molecules appear to H aggregate in the presence of DNA in addition to 
interacting with DNA in a monomeric form.  
3.2 UV-visible absorption studies of the dye interaction with duplex CT-DNA 
The significant redshift in absorption spectra of dyes in the presence of DNA as 
compared to the absence of DNA suggests that there is a strong interaction between duplex CT-
DNA and a dye (Fig 28). The disappearance of H-aggregation in dye 1, 2, and 3 and the 
appearances of two red-shifted peaks in the presence of DNA suggest that the dye aggregation is 
broken by CT-DNA. The three peaks in presence of DNA in dye 4 suggest that there is still H-
aggregation of molecules. The stability of the dyes in the presence of DNA is in the order of dye 
4 ~ dye 2 ~ dye 3 >>> dye 1. 
Since the absorption in the presence of DNA is above 700 nm, these dyes are of great 
interest for their potential use as phototherapeutic agents. Near-infrared dyes that can interact and 
cause photo damage to DNA might be potential photosensitizers that can be used for the 
treatment of tumors. 
 
 
 
 
 
 
 
 
 
Figure 28 UV-Visible spectra of 10 μM dye in presence and absence of 150 
μM bp of CT- DNA in 10 mM pH 7 sodium phosphate buffer. 
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3.3 Photocleavage at 780 nm 
Plasmid DNA was extracted from a cell culture of pUC19 transfected E. coli competent 
cells in the lab. A QIAfilterTM Plasmid Maxi Kit (25) was used to purify the pUC19 DNA. The 
obtained purified pUC19 DNA was stored in -20 °C refrigerator in 10 mM pH 7.5 sodium 
phosphate aqueous buffer. 
 
 
 
 
 
 
 
 
 
 
 
An experimental setup was prepared using a LED light and temperature control system. 
The in vitro test of the photo nuclease properties of the dyes was performed in a fume hood 
Table 3 Molar absorptivity of the peaks shown in Fig 28. 
Figure 29 Photo cleavage of 38 μM bp of pUC19 DNA by 50 μM of dye when 
irradiated with a 780 nm light (200 mW/cm2) for an hour. All the samples were 
prepared in 10 mM sodium phosphate buffer of pH 7. 
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covered by a dark foam board to prevent any leakage of light. The samples were prepared by 
using 50 μM of dye and 38 μM bp of plasmid DNA in 10 mM pH 7 sodium phosphate buffer. 
They were then irradiated with a laser light of 780 nm for an hour. After the photoreaction was 
completed, DNA damage was quantitated by running samples in a 1.3% agarose gel. The picture 
of ethidium bromide-stained agarose gel was captured by a UVP PhotoDoc-ITTM 60 imaging 
system (Fig 29).  
The extent of DNA damage can be compared in control reactions and photocleavage 
reactions. The photo reactions are seen in lane 1 – 10 in Fig 29, were conducted at ~ 10 °C. Lane 
1 and 2 are control reactions with no dye in the samples. Similarly, lanes 7, 8, 9, and 10 are dark 
control reactions. Lane 3, 4, 5, and 6 are the photocleavage reactions conducted using dyes 1, 2, 
3, 4, respectively.  Since there is a high percentage of nicked plasmid DNA as compared to 
control reactions (Lanes 1, 2, 7, 8, 9, 10) in photo reactions (Lanes 3, 4, 5, 6), it can be concluded 
that all of the four dyes tested were capable of damaging the DNA when irradiated by 780 nm 
light and might be potential drug candidates for their possible use in PDT (Fig 29). The other 
five lanes 11, 12, 13, 14 and 15 contained dyes 1, 2, 3, 4 and no dye respectively. These 
temperature control dark reactions at 37 °C do not show any significant cleavage with one 
exception. In case of dye 3, there is a slight increase in the percentage of nicked DNA upon 
raising the temperature from 10 °C to 37 °C suggesting that this dye is more thermally sensitive 
as compared to the other three. 
The order of photocleavage was dye 1 (X = H, 93 % nicked) > dye 3 (X = Br, 84 % 
nicked) > dye 4 (X = Br2, 63 % nicked) > dye 2 (X = Cl, 40 % nicked) at ~ 10 °C in 10 mM pH 7 
sodium phosphate buffer. The quantification of the gel pictures was done by using ImageQuant 
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5.2 software, and the data were plotted in Excel, as shown in Fig 30. The photocleavage 
reactions were conducted for at least three trials. Error bars represents standard deviation.  
In conclusion, all of the dyes were capable of damaging the DNA when they were 
irradiated with 780 nm laser light. The mechanism of DNA cleavage and kinetics DNA damage 
should therefore be studied. 
 
 
 
 
 
 
 
 
 
 
3.4 Kinetics of the photocleavage reaction 
Time course photocleavage experiments of plasmid DNA with 780 nm laser light were 
conducted for all the dyes at ~ 10 °C in pH 7 sodium phosphate buffer. The progress of 
photocleavage for each sample was analyzed by 1.3% agarose gel electrophoresis. The pictures 
of ethidium bromide stained gel was recorded using a UVP Photo Doc IT 60 Imaging System 
and the percentage of damaged forms of DNA was determined by using ImageQuant 5.2 version 
software. 
 
Figure 30 Quantification and calculation of % of different forms of pUC19 DNA from 
the gel picture in Fig. 29. Each bar represents average of 3 trials. The error bars 
represent standard deviation.  
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The time points for each sample were chosen as 0 s, 5 s, 30 s, 1 m, 2 m, 3 m, 5 m, 10 m, 
30 m, 60 m, and 90 m (Fig 31). From the time course gel pictures, it can be concluded that 
starting from 30 min up to 90 min, there is not much increase in the amount of photocleavage. 
Quantification of the photo cleavage as a function of time is presented in Figs 32 and 33. At 90 
min, the percentage of photocleavage is much higher in case of dye 1 as compared to other dyes 
(Fig 32). 
A plot of percentage cleaved DNA as a function of time was constructed to determine the 
order of the photocleavage reaction. 
Supercoiled plasmid + dye                                supercoiled plasmid dye complex 
[supercoiled plasmid dye complex]      [cleaved DNA] (1) 
The rate for the above equation would be: 
Rate = kobs [supercoiled plasmid dye complex]  (2)  
Figure 31 Time course photo cleavage reactions were conducted at 780 nm at ~ 10 
°C. Each sample except first lane (no compound) contained 50 μM of dye and 38 
μM bp of pUC19 DNA in 10 mM pH 7 sodium phosphate buffer. 
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Based on equation (2), the reaction rate might be zero order, first order, or second order. In an 
integrated rate equation if a plot of [form of DNA] vs. time is made and if the data fit the linear 
model, then the reaction is considered a zero order rate equation. If a plot of ln [form of DNA] 
vs. time fits a linear model, then it is a first order reaction. If a plot of 1/ [form of DNA] vs. time 
fits a linear model, then it is a second-order reaction. In all cases, observed rate constant would 
be the slope of the equation, and the half-life of the reaction can be calculated using the rate 
constant value. The plots were made for all the dyes to check the order of a reaction (Fig 34 
shows plots for dye 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32 A plot of the percentage of photocleaved DNA as a function of 
time. The average of three trials was plotted. Error bars represent standard 
deviation. This figure is the quantification of Fig 31. 
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None of the three plots a, b, and c in Fig 34 for dye 3 gives the linear fit of the 
experimental data. This suggests that the calculation of the observed rate constant and hence the 
half-life of the photocleavage reaction is not possible using linear least square regression 
modeling. Cowan and coworkers talked in detail about the kinetics and rate constant calculations 
in their publication in the case of metal complex assisted DNA cleavage. They reported that 
kinetics of Cu2+-neamine cleavage of DNA fits the single exponential decay curve, i.e., pseudo 
first order kinetics.69 According to the authors, the linear regression of the exponential decay can 
be explained by the mathematical equation: 
   Y= (100-Y0)[1-exp(-kobs*t)]   3
 
Where, Y0 is the percent of a form of DNA at 0 s irradiation time, kobs is the observed rate 
constant, Y is the percentage of the form of DNA at time t.69  
Figure 33 A plot of % DNA photocleavage as a function of 
time. The cleaved % of DNA in each sample was 
quantified by using the gel pictures shown in Fig 31. The 
average of three trials was taken for each data point. 
Error bars represent standard deviation. 
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In Fig 35, experimental data were plotted for dye 3, and then the model was built using 
equation 3. The least square fitting system was used to calculate the value of the rate constant. 
The obtained value from the model was Kobs = 1.09 min
-1. By using this value, the calculated 
half-life for the dye 3 time course kinetics is 38.5 seconds. Unfortunately, this value does not 
look consistent with the gel pictures in Figs 31.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Since the kinetic equations were not able to give the trusted value of the rate constant and 
the half-lives of the kinetics for all the dye-DNA photocleavage reactions, apparent half-lives of 
the photocleavage reactions were estimated using Fig 33. The time points at which 50% of the 
Figure 34 A plot of the percentage cleaved DNA as a function of time for the dye 3. 
various plot of the same data were made in order to check the rate of a reaction. 
Each sample contained 38 μM bp of DNA and 50 μM of dye in 10 mM sodium 
phosphate buffer. Samples were irradiated at 780 nm at ~ 10 °C. Each datum point 
is the average of three trials. Error bars represents standard deviation.  
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DNA was cleaved were all less than 5 min. The order of apparent half of the photocleavage 
reaction was in the order of dye 2 > dye 4 > dye 3 > dye 1. The less stable dye1 has the fastest 
kinetics as compared to all the halogen substituted dyes. 
 
 
 
 
 
 
 
 
 
3.5 Binding affinity 
If the two species have the same absorptivity at a particular wavelength, then the total 
absorption of their mixture remains same at that wavelength regardless of the ratio of those two 
species as long as the total concentration remains same. The wavelength at which the absorption 
of two species remains same despite their proportion, keeping the total concentration the same is 
called an isosbestic point. This can be explained by using Beer-Lambert law: 
A = ɛ c l 
At the isosbestic point, absorbance remains constant, and two species have same molar 
absorptivity. According to Sanjeev et al., the following are the general condition for the 
occurrence of an isosbestic point:70 
1. If two species are X and Y, then CX + CY = C, where the C remains constant. 
Figure 35 Model building for the pseudo first order 
kinetics. 
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2.  ɛX = ɛY = ɛ 
3. The absorbance of two species adds up linearly in various ratios to get constant 
absorbance at an isosbestic wavelength, and it is unlikely to get linear add up at isosbestic 
wavelength when the sample has more than two species. 
Number of species in a drug-DNA interaction 
Regarding the number of species present, an isosbestic point suggests that two species are 
present in a sample in different ratios to give an isosbestic point because linear adding up of 
absorption at a particular wavelength is highly unlikely for more than two species. Let us 
assume, two species drug and DNA have the same molar absorptivity at a specific wavelength in 
the following equation:  
Drug + DNA                      [drug-DNA] 
Suppose at a particular wavelength the absorbance of 100 % drug = 0.5, 100 % DNA = 0 
and 100 % [drug-DNA] = 0.5 then, at the isosbestic point, the absorbance is always 0.5 
regardless of the ratio of the drug and drug-DNA complex. This would be true only in case there 
are two species absorbing at the isosbestic wavelength. If there are more than two species 
absorbing at the isosbestic wavelength, then the absorbance is not going to add up linearly. This 
means that the isosbestic point would not be seen. 
Small molecules can be bound with the duplex DNA in multiple ways to give different 
drug-DNA complexes. Depending upon the mode of binding or in some cases the angle of 
binding, types of drug-DNA complexes vary in the same sample. Each mode of binding in drug-
DNA interactions can be considered a different species that might or might not absorb light at the 
isosbestic wavelength. There might be more than two species that absorb at the isosbestic point 
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due to multiple binding modes, and since it is unlikely to add up absorbance linearly for more 
than two species, the probability of seeing a clear isosbestic point can be minimum.71,72 
In a sample containing 25 μM dye 1 through 4, 1 μL increment of 2500 or 5000 μM bp of 
CT- DNA were added, and the absorption spectra were recorded (Fig 36). The DNA was added 
until the titration reached a saturation point. The DNA concentration at which no change in 
absorption was observed even after addition of 1 μL of 5000 μM bp DNA was considered the 
saturation DNA concentration. The saturation point was achieved in all of the dye-DNA 
titrations when the total DNA volume added was less than 20 μL. The absorbances for the entire 
dye-DNA ratio were corrected by a dilution factor. 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 36 UV-visible titration of the 25 μM of a dye in 10 mM pH 7 sodium phosphate 
buffer. Each spectrum was recorded after the addition of 1 μL of 2500 or 5000 μM bp 
CT-DNA. The numbers in the legends are the DNA concentrations in μM bp. 
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The λmax values of dyes 2, 3, and 4 were red-shifted upon DNA addition. In the case of 
dye 1, the absorption maximum keeps on going down with the increase in the concentration of 
DNA confirming our initial observation that the dye is not stable even in the presence of DNA 
(Fig 25). In case of dyes 2, 3, and 4, absorption goes down on the left side of the spectra, but it 
goes up on the right side of the spectra possibly indicating a change in the aggregation state of 
the DNA bound dye from a higher order H-aggregate to a lower order aggregate or a monomer. 
In all cases, dye to DNA binding saturation was reached at a dye to DNA bp ratio of ~1:4. In dye 
4, there is still a major aggregation peak (left side) in addition to two red-shifted peaks 
suggesting that this dye is binding differently as compared to dyes 2 and 3. The lack of a clear 
isosbestic point in all the spectra suggests that there are more than one species of dye-DNA 
complex. This might be a good indication of multiple binding modes.  
If the absorption titration is conducted by keeping the fixed concentration of drug and 
increasing the concentration of DNA, then for any given ratio of drug/DNA, determination of the 
concentration of the free drug and bound drug would be extremely difficult. To find the 
equilibrium constant, the values of the molar extinction coefficients of free drug (Ɛf) and bound 
drug (Ɛb) are needed. In addition to that, the amount of drug (r) bound per unit of DNA as a 
function of added DNA is needed. Once the free drug concentration and amount of drug bound at 
a particular drug/DNA ratio are determined then the value of intrinsic binding constant (Ki) is 
given by the following equation,73  
r / Cf = Ki(n – r)  (1) 
where n is the number of DNA binding sites occupied by the bound drug and Cf is the free drug 
concentration. 
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Since the calculation of binding affinity using equation 1 is complicated in case of drug-
DNA interactions, Meehan and coworkers developed a model which is a slight modification of 
the equation 1 and works for the small molecule-DNA interaction.61 They have studied the 
binding of pyrene and benozopyrene derivatives with duplex DNA and calculated the binding 
affinity using the equation in Fig 37, 
 
 
 
 
where Kb is an apparent binding affinity, Ɛa is an apparent molar absorptivity of the free drug, Ɛb 
is a molar absorptivity of a bound drug in a particular drug DNA ratio, and Ɛf is a molar 
absorptivity of a free drug with no DNA added. 
The values of the parameters in the equation (Fig 37) were calculated by monitoring the 
wavelength at which a decrease in the absorbance of the DNA bound H aggregate was observed. 
The peaks at 558 nm, 570 nm and 580 nm represent the absorbance maxima (λmax) of the free 
drug in spectra of dyes 2, 3, and 4 respectively (Fig 36). The peaks at 570nm, 580 nm, and 580 
nm represent the λmax of the DNA bound H-aggregate complexes of dyes 2, 3, and 4 respectively. 
The decrease in absorbance of the DNA bound H aggregate peaks represent the disappearance of 
one form of complex (H-aggregation complex) and formation of another form of complex (lower 
order aggregation or monomeric bound complex). The absorbance at which there is no DNA 
gives the value of Ɛf. The absorbance for the other drug-DNA ratios gives the value of Ɛa for that 
drug-DNA ratio. Once the values of Ɛf and Ɛa are calculated from the spectra, then a linear plot 
can be made by keeping the values of [DNA]/( Ɛa - Ɛf ) as Y-ordinate and [DNA] as X-ordinate. 
Figure 37 The linear regression plots were made by 
using this equation to calculate the apparent 
binding affinity of a drug-DNA interaction. 
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The linear fit of the data was made, and the values of slope and intercept were computed from 
the generated equation of the linear line.62 When the values of slope and intercept are obtained, a 
ratio of slope and intercept gives the value of binding affinity Kb (Fig 38). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The calculated binding affinity values for dye 2, 3, and 4 are 6.4 * 104 M-1 bp, 5.9 * 104 
M-1 bp, and 7.3 * 104 M-1 bp. The binding constant for dye 1 could not be calculated because the 
dye 1 is unstable. When calculating the binding constant values, a few points at the beginning of 
the plot were removed as outliers. The order of binding affinity is dye 4 > dye 2 > dye 3.  
Now based on the binding affinity, apparent half-life, photocleavage, and stability in 
presence and absence of DNA experiments, we can select a lead compound for detail 
investigation. The following are the conclusion of the above experiments: 
Figure 38 Based on the equation in Fig 37, linear plots were made to 
calculate apparent binding constants. Representative plots appear 
above. Each binding constant was averaged over three trials. Error is 
represented as standard deviation. 
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1. Order of binding affinity of dyes to DNA: dye 4 > dye 2 > dye 3 
2. Order of stability in 10 mM pH 7 sodium phosphate buffer: dye 2 ~ dye 3 ~ dye 4 >>> 
dye 1   
3. Order of stability in presence of CT-DNA in 10 mM pH 7 sodium phosphate buffer: dye 
4 ~ dye 2 ~ dye 3 >>> dye 1 
4. Order of DNA photocleavage sensitized by 780 nm light: dye 1 > dye 3 > dye 4 > dye 2 
5. Order of apparent half-life of DNA photocleavage reactions: dye 4 > dye 2 > dye 3 > dye 
1 
Dye 1 is unstable in water in presence and absence of DNA. Among dye 2, 3, and 4, dye 
3 has highest photocleavage efficiency and moderate stability in 10 mM sodium phosphate pH 7 
buffer. Dye 3 also has relatively higher apparent half-life of photocleavage reactions when 
compared to other moderately stable dyes 2 and 4. This gives us a choice of dye 3 as a lead 
compound for further investigations. 
3.6 Competitive binding mode study 
The intercalator ethidium bromide, the minor groove binder pentamidine, and the major 
groove binder methyl green were used to study the binding modes of the dye 3. Displacement of 
dye 3 at its saturation concentration with CT-DNA was studied using UV-visible 
spectrophotometry. 
3.6.1 UV-visible competitive displacement study with ethidium bromide 
Ethidium bromide, a well-known intercalator, was used in the displacement study of dye 
3 from the dye-DNA complex. The final sample had 20 μM of dye 3 with 100 μM bp of CT-
DNA in 10 mM pH 7 sodium phosphate buffer. The sample was equilibrated for 5 min after 
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which an initial spectrum was recorded. Then, the concentration of ethidium bromide was raised 
by adding aliquots of 2500 μM solution of ethidium bromide as shown in Fig 39 B.  
 
 
 
 
 
 
 
 
 
 
 
The free compound peak is seen at 570 nm. Similarly, two peaks are seen around 700 - 
800 nm for the dye-DNA complex. When ethidium bromide is added, a gradual decrease in 
absorbance of dye-DNA complex peak is observed as seen in Fig 39 B. In the meantime, an 
increase in peak intensity at 570 nm occurs. This suggests that ethidium bromide is displacing 
dye 3 from the dye-DNA complex, and near complete displacement appears to occur when 
ethidium bromide's concentration is 50 μM or more. At a final concentration of 75 μM of 
ethidium bromide, another peak around 500 nm is seen. This peak is the signature peak of an 
ethidium bromide-DNA complex, which indicates that most of the bound dye is displaced from 
DNA. As shown in Fig 39 A, the order of addition in the sample preparation also does not affect 
the amounts of dye 3 displacement. Spectra were recorded when the samples were prepared in 
Figure 39 The displacement of dye 3 from 20 μM-100 μM bp dye-DNA complex in 10 
mM sodium phosphate buffer by ethidium bromide was monitored using UV-visible 
spectrophotometer. (A) representative concentration from full titration, (B) full 
titration. 
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the order of addition as DNA-EtBr-dye and DNA-dye-EtBr. In both cases, displacement of dye 
was observed about the same amount. This suggests that ethidium bromide, an intercalator is 
displacing dye 3 from DNA, and this information might be important in predicting the binding 
mode of the compound.  
Since ethidium bromide is displacing compound, one might think that the binding mode 
of the dye is intercalation. Before making any conclusion, other major factors that are related to 
binding mode need to be addressed. The diameter between two strands and rise of each base pair 
along the axis of DNA play a crucial role in allowing a molecule to intercalate. The size and 
characteristics of the molecules themselves are also essential factors for DNA binding. Another 
important factor is the affinity of ethidium bromide as compared to the dye towards the DNA. 
Considering the phenanthridinium ring connected by the pentamethine bridge, the width 
of the molecule appears to be more than average space between two base pairs (3.4 Å). Because 
of the rigid pentamethine bridge, it can be expected that the heterocyclic ring in the dye cannot 
insert flat and stack between the DNA base pairs. The other small molecules such as berenil and 
pentamidine have similar kinds of structures as dye 3, and they are groove binders. The width of 
the average minor and major groove in B form of DNA is around 12 Å and 22 Å respectively. 
Since the hydrophobic effect also plays a vital role in groove binding of small molecules, if there 
is a monomeric binding a tight fit might be expected in case of minor groove binding for the dye 
3. If there is dimeric or polymeric binding, then it might be expected that the binding could be in 
either major or minor groove. 
There is a universal agreement that ethidium bromide is a high-affinity binder to duplex 
DNA. In low concentration, it is an intercalator, and at high EtBr to DNA ratios, some of the 
molecules bind to the DNA groove.74 Several studies have been published regarding the binding 
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properties and binding affinity of ethidium bromide with duplex DNA. Most of them calculated 
the binding affinity using the formula and method developed by McGhee and Hippel using a 
Scatchard plot.73 Bi and coworkers calculated the binding constant value of ethidium bromide 
with CT-DNA in a pH 7.4 (H3BO3+H3PO4+HAc) buffer. The value they calculated was 2.6 * 10
6 
M-1. 75 Similarly, another paper reported 3.3 * 105 M-1 base pair, when they calculated the 
binding constant value using CT-DNA in pH 7.5 Tris-HCl (5 mM) buffer with an ionic strength 
0.1M NaCl. 76 Under ammonium fluoride (0.5 M) high salt condition, the value calculated was  
2.0 * 104 M-1 in 2 mM MES buffer of pH 6.3.56 The molecular modeling study of the binding of 
ethidium to the duplex DNA calculated an increase in double helix diameter of duplex DNA by 
0.34 Å, when ethidium bromide molecules intercalate between DNA base pairs.77,78 
The oversize ring structure and rigid methine bridge of dye 3 might make it difficult for 
both rings to simultaneously fit into an intercalative position. Thus, the displacement of the dye 
by ethidium bromide might in part be explained by the higher affinity of the EtBr to DNA as 
compared to the dye 3. It might be expected that when EtBr binds to the DNA, the resulting 
structural changes might not favor the noncovalent binding of the dye. This could lead to the 
displacement of dye from DNA. 
3.6.2 Displacement study by minor groove binder pentamidine 
Displacement by the minor groove binder pentamidine was studied to check whether dye 
3 is binding in minor groove of duplex DNA. A pentamidine solution was prepared in DI water 
and used immediately. A final concentration of 50 μM of pentamidine was added in the sample 
containing 20 μM of dye and 100 μM bp of CT- DNA. The same reaction mixture was prepared 
again in another sample where the order of addition is reverse, i.e., DNA was equilibrated first 
with 50 μM of pentamidine then dye was added (final concentration of dye was 20 μM). The 
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recorded spectra for both sets of samples were compared. Similar experiments were conducted 
using 100 μM of pentamidine. In all cases, it was observed that the intensity of the dye-DNA 
peak was increased in the presence of pentamidine (Fig. 40). This suggests that either the dye is 
not binding in the minor groove or that the pentamidine is unable to displace or block the dye 
from binding in the minor groove. Further, when looking at 570 nm where there should be a peak 
of free compound, no additional peak is observed in the case of DNA-dye-pentamidine complex 
as compared to the dye-DNA spectrum. This further proves that the dye is not displaced from the 
DNA by pentamidine. It can also be said that the pentamidine was unable to block the dye from 
binding to DNA.  
All of these observations lead to the two hypotheses about dye binding to the duplex 
DNA. First, either binding affinity of pentamidine is lower as compared to dye or second, dye is 
binding into the major groove of the DNA. Several papers are published regarding the binding of 
pentamidine in the DNA minor groove. Neidle and wo-workers studied the binding of 
pentamidine and its homologue propamidine to DNA dodecamer d(CGCGAATTCGCG)2 by 
using their crystal structure. They found that both pentamidine and propamidine causes the 
decrease in minor groove width at the binding site. Moreover, they found that both compounds 
prefer to bind in the AT rich region of the DNA minor groove.79 Some of the papers have also 
calculated the binding constant of the pentamidine using Scatchard plots. The formula was 
derived by McGhee and Hippel and modified by other scientists. We have used a similar kind of 
approach to calculate the binding affinity of dye 3. The paper published by Kellet and coworkers 
calculated the binding constant of pentamidine by using EtBr displacement assay. They prepared 
the samples by using CT-DNA in the pH 7 buffer of 10 mM TES mixed with 0.1 mM Na2EDTA. 
The value of the binding constant of pentamidine with CT-DNA they calculated was 6.07*105 
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M-1 bp.80 In the case of dye 3, the binding constant value we calculated is 5.9*104 M-1 bp. Thus, 
we can conclude that the binding affinity of dye 3 may be lower than the binding affinity of 
pentamidine towards CT-DNA. Zsila and coworkers conducted UV-visible titrations to calculate 
the binding constant of pentamidine with heparin in pH 7 phosphate buffer. Their calculated 
value is 1.6*105 M-1.57 
 
 
 
 
 
 
 
 
 
  
Since the DNA binding affinity of pentamidine appears to be higher as compared to dye 3 
and there is no blocking or displacement of dye 3 by pentamidine, it can be hypothesized that the 
dye might be binding in the DNA major groove. To test this hypothesis, we used methyl green, 
which is a major groove binder, and the experiments were conducted using UV-visible 
spectrophotometer. 
3.6.3 Displacement study by the major groove binder methyl green 
Methyl green, a major groove binding small molecule, was used to study the 
displacement study in UV-visible spectroscopy similar to pentamidine and ethidium bromide. 
Figure 40 Displacement of a dye by minor groove binder pentamidine. 
The saturated samples contained 20 μM of dye and 100 μM bp of CT-
DNA in 10 mM pH 7 sodium phosphate buffer. The spectra were 
recorded using UV-Visible spectrophotometer. 
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Most of the small molecules were thought to bind in the minor groove except some metal 
complexes until the study of the binding mode of methyl green using the triple helix poly(dA).2 
poly(dT) was published.58 The displacement samples contained 20 μM of dye and 100 μM bp of 
CT-DNA. Spectra were recorded over a gradual increase in the concentration of methyl green in 
a dye-DNA sample (Fig 41).  
 
 
 
 
 
 
 
 
 
There is an overlap in the spectrum of dye-DNA complex with the DNA-methyl green 
complex in the 500-700 nm range, but at wavelengths higher than 700 nm, there is no overlap so 
one can look in this region to see if there is any dye displacement when the concentration of 
methyl green is raised in a dye-DNA complex (Fig 41). 
When the methyl green concentration was increased, there is a clear decrease in the 
absorbance of the dye-DNA complex on the right side of the spectra suggesting that dye may be 
binding in the DNA major groove. The amount of displacement is same regardless of the order 
of reagent addition to the sample. In Fig 42 (C and D), the spectral signature is at the same place 
when the order of addition is DNA-dye-methyl green vs. DNA-methyl green-dye. There could 
Figure 41 UV-visible displacement studies as a functionof methyl 
green concentration.  The sample contained 20 μM of dye and 100 μM 
bp of DNA in 10 mM pH 7 phosphate buffer. 
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also be a methyl green induced change in DNA structure that is causing displacement of dye. 
The binding affinity of the methyl green compared to dye 3 needs to be considered before 
making any conclusion about the dye 3 binding mode. The binding constant value calculated for 
methyl green by Liu and coworkers is 8.8*104 M-1.81 They used CT-DNA in pH 6.87 tris HCl (5 
mM) buffer to record the spectra in UV-visible spectrophotometer and calculated the binding 
constant. Chaires and coworkers published a paper that showed the calculations of fluorescent 
indicator displacement by thirty different ligands. According to them binding affinities of the 
ligands to DNA oligonucleotides follow in the order of ethidium bromide > pentamidine > 
methyl green.82 Methyl green is a relatively weak binder to duplex DNA; however, it is stronger 
binder as compare to dye 3 (kb = 5.9 * 104 M-1 bp). Considering the minimal conformational 
stress exert by the methyl green on duplex DNA83,84,85, the displacement of the dye 3 by methyl 
green might indicate that the dye is a weak major groove binder. Further study and discussions of 
the binding mode to verify this hypothesis are described in the following sections. 
 
 
 
 
 
 
 
 
 
 
Figure 42 Summary of the UV-visible competitive binding mode studies. Displacement 
by pentamidine (A), ethidium bromide (B), and methyl green (C and D) when they 
were added in a sample that contained 20 μM of dye and 100 μM bp of DNA in 10 mM 
sodium phosphate buffer of pH 7. 
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3.6.4 Competitive photo cleavage inhibition assay 
In the previous section, we discussed about the binding affinities of the well-known 
intercalator ethidium bromide, minor groove binder pentamidine, and major groove binder 
methyl green. In a photocleavage reaction, if one of these binders is equilibrated before the 
addition of dye 3, inhibition of DNA photocleavage might occur if the binding mode of one of 
the well-known binders matches the binding mode of dye 3. Alternatively, the competing ligand 
could change DNA structure preventing the dye from binding. 
 Based on these hypotheses, three samples were prepared in which each had 50 μM of 
known binder pre-equilibrated with 38 μM bp of pUC19 DNA at 10 mM pH 7 sodium phosphate 
buffer. Then in each sample, dye 3 was added (final conc. = 50 μM) and equilibrated for 5 min. 
Each sample was irradiated at 780 nm for an hour at ~ 10 °C, and agarose gel electrophoresis 
was conducted for all the samples and controls (Fig 43). 
 
 
 
 
 
 
 
 
 
 
 
Figure 43 Gel picture showing photocleavage 
inhibition, when competing binders were added to 
the dye-DNA sample at 10 °C. The samples were 
prepared by mixing 50 μM of dye, 38 μM bp of 
DNA and 50 μM of competitor in 10 mM pH 7 
sodium phosphate buffer. Abbreviations: D: 
dark, L: light, P: pentamidine, M: methyl green, 
3: dye 3, E: EtBr, P3: pentamidine+dye3, M3: 
methyl green+dye3, E3: EtBr+dye3. 
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In a dark control (D), dye 3 was equilibrated with pUC19 DNA and kept in the dark. In a 
light control (L) control, pUC19 without dye was irradiated for an hour at 780 nm. In controls P, 
M, and E, DNA was equilibrated with pentamidine, methyl green, and ethidium bromide 
respectively and was irradiated with the 780 nm laser light for an hour. In all controls, no 
photocleavage was observed. A sample named 3 was prepared by equilibrating dye 3 with 
pUC19 DNA and was irradiated with 780 nm light for an hour. The photocleavage of samples 
pre-equilibrated with pentamidine, methyl green, and ethidium bromide followed by the addition 
of dye 3 is seen in lane P3, M3, and E3 respectively. In the case of lane P3, only a small amount 
of photo inhibition was observed, suggesting that dye 3 is may not be a minor groove binder. 
Lane E3 has some inhibition of photocleavage but considering the structure of the dye 3, bis 
intercalative binding mode may not be possible. Instead, the projection of phenyl and ethyl group 
of the ethidium bromide in the major groove might be the reason for inhibition. 
 
 
 
 
 
 
 
 
 
 
Figure 44 Gel quantification of Fig 43. Each bar represents average of 3 trials. 
Error bars represents standard deviation. 
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Although Fuller and Waring in 1964 studied the X-ray diffraction and molecular 
modeling of the ethidium binding to DNA and predicted that the phenyl and ethyl substitution at 
N+ cation of ethidium bromide goes towards the major groove, in 1977 Jain et al. used NMR and 
visible spectroscopic techniques and predicted that intercalated ethidium bromide has its 
substituents group in minor groove of the duplex DNA.86 Later on in other papers, scientist 
agreed that intercalated ethidium bromide substituents lie in the minor groove while the 
electrostatically stacked ethidium bromide substituents orient in the major groove.87 This 
suggests that ethidium bromide can inhibit the photocleavage by displacing the dye from the 
grooves, both major and minor. In addition to that, when ethidium bromide binds to the DNA, it 
causes the unwinding of DNA. Due to this change in dimensions and helical structure of the 
DNA, the dye might fall off from the DNA grooves resulting in photocleavage inhibition. In lane 
P3, there is the least photocleavage, suggesting that pentamidine is unable to prevent the dye 
from binding. This result is consistent with the data obtained from the competitive displacement 
assay. The reaction in lane M3 shows that the most inhibition of photocleavage is by methyl 
green. Methyl green has the weakest DNA affinity out of three competitors that are talked in this 
section. Methyl green, which is a weak major groove binder, inhibited the photocleavage the 
most and the result is consistent with the UV-visible displacement experiment (Fig 44). This 
could be the evidence that dye 3 is binding in the DNA major groove.  
3.7 Circular dichroism (CD) experiments suggest groove binding 
Although circular dichroism affords lower structural resolution as compared to NMR and 
X-ray crystallography, it can provide information on the real-time interactions of molecules in a 
solution. CD analysis makes the study of the secondary structures of protein and DNA under 
physiological conditions possible. NMR that requires low pH and high concentration and X-ray 
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that requires crystals are other effective tools to understand the structural activity relationship of 
drugs binding to DNA. In CD, ligand or drug binding with DNA can be studied by observing 
induced CD (ICD) or change in CD signals of biomolecules by small ligands. Moreover, thermal 
stability, the effect of pH, effect of ionic strength, and concentration on a particular biomolecule 
can be studied. 88,89 
 
 
 
 
 
 
 
 
 
 
 
 
 
Circular dichroism is the difference in absorption of left-handed circularly polarized light 
(LCPL) and right-handed circularly polarized light (RCPL) by a chromophore that contains one 
or more chiral centers. 
Circular dichroism = ∆A(λ) = A(λ)LCPL – A(λ)RCPL  
Figure 45 CD spectra and absorbance spectra recorded at room temperature. Samples 
were prepared by mixing 20 μM of dye and 150 μM of CT-DNA in 10 mM pH 7 sodium 
phosphate buffer. Full range plot (A), 340 – 900 nm(C), 220 – 340 nm(B). 
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The difference between the absorptions of circularly polarized light was measured by using 
Jasco-810 CD spectrophotometer. The experiment was conducted at room temperature. The 
samples were prepared in 10 mM pH 7 sodium phosphate buffer that contained 20 μM of dye 
and 150 μM bp of CT- DNA. Each sample was scanned over twelve accumulations using a 1 cm 
3 mL quartz cuvette. The instrument was set in a high sensitivity mode with a 0.5 nm pitch, a 
100 nm/min scan speed, and a 2 second response time. The near-infrared extender was connected 
when recording the induced CD at wavelengths higher than 600 nm. 
The binding of a small molecule with a DNA molecule can be studied by analyzing its 
ICD signal in the DNA CD spectrum. DNA is an optically active chiral molecule, and the 
difference in an asymmetry of a chiral molecule generates the CD signal. Many interacting 
molecules are optically inactive; however, when they bind to DNA, they can acquire an induced 
CD through the coupling of electrical transition moments of ligands and DNA. The presence of a 
DNA ICD for an achiral molecule itself is an indication of a drug-DNA interaction. Depending 
upon the molecular axis of ligand and electric and magnetic transient moments of the dyad and 
helixes of DNA, ICD signatures are different. Based on the nature of CD and ICD signal, 
binding affinity and binding mode of a ligand can be interpreted. Generally speaking, an 
intercalator has a weak ICD signal as compared to the ICD of DNA groove binder. A DNA 
major groove binder has a more variable ICD signal as compared to minor groove binder as the 
major groove has a larger space for a molecule to change its orientation and reposition. 
Furthermore, the exciton CD signal is a result of dimeric or higher order binding in a groove or 
external stacking binding mode. An exciton signal is a bisignate CD signal with a positive and a 
negative peak. Monomeric binding and intercalation do not give any exciton signal. 90,55 
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Since the ethidium bromide has a phenanthridinium ring and dye 3 has phenanthridinium 
rings connected by a five carbon methine bridge, conceivably they might exhibit similar kinds of 
binding to duplex DNA. As previously mentioned in section 4.6.4, ethidium bromide in low 
concentration binds with DNA through intercalation with its substituent phenyl ring and ethyl 
group in the minor groove. At high concentration, in addition to intercalation, ethidium bromide 
externally stacks through electrostatic interactions with negatively charged DNA phosphate 
backbone oxygen atoms. When it stacks, its substituents lay in the major groove. These 
conclusions were made from the study of Laugaa et al. (1983) and Waring (1965).86,87,74,56 
Now, taking into consideration the binding mode of ethidium bromide and its structural 
similarities with dye 3, we can put forth ideas about the binding of the dye 3 with duplex DNA. 
The first possibility is intercalation. Because of the rigid pentamethine bridge that connects two 
phenanthridinium rings, the possibility of fitting both rings of the molecule into the DNA base 
Figure 46 ICD of ethidium bromide binding to DNA at room 
temperature. The sample contained 20 μM of ethidium bromide and 
100 μM bp of CT-DNA in 10 mM pH 7 sodium phosphate buffer. 
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pairs might be excluded. This argument is supported by the exciton peak in the CD spectra as 
exciton peak cannot be observed in the case of intercalation (Fig 47 c).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ethidium bromide molecules are not known to bind in the minor groove. The same might 
be expected for dye 3 and is supported by competitive displacement and competitive 
photocleavage inhibition studies. EtBr also not known to bind deeply in the major groove; 
Figure 47 Circular dichroism titration recorded at room temperature. The sample was 
prepared in 10 mM pH 7 sodium phosphate buffer. To a fixed concentration of dye 3 (20 
μM), increasing amount of CT-DNA were added. The number on the legends represents 
concentration in μM bp. Full range spectra 220-850 nm(A), 600-1000 nm (B), 500-700 
nm (C), 220-340 nm (D). 
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however, they are known to bind externally with their phenyl and ethyl group laying into the 
DNA major groove. This might also expected in case of dye 3. 
At a high ratio of dye to DNA, intense bisignate CD peak at 500-600 nm wavelengths is 
observed. This suggests that a large number of dye molecules are H-aggregated in a DNA 
groove, conceivably the DNA major groove. The similarity of the bisignate CD peak of dye 3 
and bisignate CD peak for well-known major groove binder methyl green in addition to the dye 3 
displacement by methyl green in displacement study support this binding mode (Fig 42).58 This 
claim is also supported by the CD titration of the fixed concentration of dye with increasing 
amount of CT-DNA in CD spectra (Fig 47 c). When the DNA concentration was increased, the 
bisignate CD signal in the 500-600 nm region disappears and a weak signal appears in the 700-
800 nm region. This suggests that at lower drug-DNA ratio, lower order aggregation of 
molecules possibly dimeric or monomeric binding is happening either in DNA major groove or 
in an intercalative position. 
 In the photocleavage study, only a 780 nm light source was used. UV-visible spectra 
show that this wavelength belongs to putative monomeric or low order aggregate binding. The 
fact that there is a weak bisignate ICD signal in 700-800 nm region rules against intercalation 
and monomeric binding since neither of these modes is capable of generating bisignate signal. 
3.8 Fluorescence properties 
The potential of a dye as a biomolecular labeling agent depends upon its fluorescent 
properties. A photosensitizer, when excited into higher energy state, might have multiple fates as 
shown in the Jablonski diagram (Fig 1). It can either go back to its ground state by emitting 
fluorescence or go towards its triplet state by intersystem crossing. Once it reaches the triplet 
state, it can either go back to the ground state by phosphorescence or can transfer electron or 
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energy to surrounding molecules. These pathways depend on the lifetime of the triplet states, the 
relative rates of the competing reactions, molecules or atoms that quench the triplet state, and 
molecules or atoms that play roles in the intersystem crossing. L. Shi et al. showed the photo 
cleavage of duplex DNA by a compound where an H atom in the molecule was replaced by F, 
Cl, Br, and I. They found the percent cleavage was higher in case of Br and I substituted 
compounds as compared to F and Cl.91 Although intersystem crossing (ISC) is a process which 
involves multiple factors, it has been reported that ISC is higher in the molecules which contain 
heavy atoms such as bromine and iodine due to spin-orbit coupling. Similarly, it is also reported 
that the molecules that contain paramagnetic atoms also have a higher rate of the intersystem 
crossing.92,93 The quenching of fluorescence by I, Br, and Cl was studied by S. Foley et al. and 
they reported that the order of quenching is I > Br > Cl.94 Another paper published by Gunther 
Von Bunau studied the triplet state life time of anthracene compounds. They noted that triplet 
state quenching is higher in case of bromine and iodine as compared to chlorine and fluorine-
substituted compounds.95 Taking into considerations of all of these factors, we can expect higher 
photo cleavage in case of Br substituted dye as compared to Cl. But a very heavy atom might 
contribute to shortening of triplet state lifetimes; hence photocleavage could be less efficient. 
Similarly, one can expect higher fluorescence in case of light halogen substituted molecules as 
compared to heavy halogen substituted analogs. 
Fluorescence spectra were recorded for all the dyes of interest using a PerkinElmer LS55 
fluorescence spectrophotometer. Samples were prepared in the presence and absence of CT-
DNA in 10 mM pH 7 sodium phosphate buffer. The excitation wavelength was chosen based on 
the absorption peaks of the dye. Dye 3 was excited at 566 nm and 619 nm in the absence of CT-
DNA. Similarly, it was excited at 580 nm, 672 nm, and 722 nm in the presence of CT-DNA (Fig 
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48). In all of the excitation wavelengths, only light scattering bands are observed. This might 
indicate that most of the excited molecules are going to the triplet state and contributing to the 
generation of ROS.  
 
 
 
 
 
 
 
 
Cyanine dyes that intercalate show enhanced fluorescence as compared to those which 
binds in grooves.2 Ethidium bromide, a well-known intercalator, fluoresces intensely in presence 
of DNA as compared to absence of DNA (Fig 49). Since the putative monomeric/low order 
aggregated form of dye 3 does not show any fluorescence even in presence of DNA, this 
suggests that the dye may not be intercalating. 
 
 
 
 
 
 
 
Figure 48 Emission spectra of the 20 μM of dye 3 in presence and 
absence of 150 μM CT-DNA in pH 7 sodium phosphate buffer 
recorded in room temperature. Since this dye is not fluorescent, 
the emission spectra are not seen, instead the light scattering 
artifacts at the excitation wavelengths are presented. 
Figure 49 Emission spectra of 5 μM of ethidium bromide in presence of 100 μM bp 
of CT-DNA in 10 mM sodium phosphate buffer of pH 7.0 (λexc = 520 nm). 
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3.9 Reactive Oxygen Species Detecting Probe 
In NIR PDT, there is a challenge to produce PS triplet state that is high enough in 
energy to generate ROS. According to the manuscript written by Dr. Kathryn B. Grant 
with assistance from Kanchan Basnet, when the excitation wavelength of the 
photosensitizer shifts to longer wavelengths, it becomes very difficult for photo 
sensitizers to generate reactive oxygen species. They also reported that the upper 
wavelength limit for photosensitized 1O2 production is ~ 810 nm. Similarly, for the 
generation of hydroxyl radicals, the oxidation of triplet excited state of photosensitizer 
should be higher than oxidation potential of ground state oxygen. The excitation energy 
decreases when the excitation wavelength shifts towards longer wavelength, resulting the 
decrease in oxidation potential of triplet state photosensitizer. Because of this reason, it is 
very difficult to find photosensitizer that damage DNA at wavelength higher than 800 nm. 
 
 
 
 
 
 
 
 
 
 
 
Figure 50 Mechanism of detection of ROS by HPF and SOSG. 
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HPF (2-[6-(4-hydroxy)phenoxy-3H-xanthen-3-on-9-yl]benzoic acid) was synthesized by 
Setsukinai et al. and was tested for their specificity and potential for the detection of reactive 
oxygen species. They reported that HPF is selective to detect qualitatively reactive oxygen 
species such as •OH, 1O2, O
•
2
-. When benzoquinone is attached to fluorescein, HPF is not 
fluorescent, but, in the presence of these reactive oxygen species benzoquinone is lost to generate 
fluorescence product (Fig 50).96,97 Since HPF can detect the presence of ROS in a sample, we 
hypothesized that if any ROS were to be produced during the photocleavage reaction, they could 
react with HPF. This way, the involvement of a specific type of ROS in the photocleavage 
reaction could be detected. 
  
 
 
 
 
 
 
 
 
A stock solution of 5 mM HPF was prepared by dissolving the HPF powder into DMF 
and then stored the resulting solution in a -4 °C refrigerator. Each HPF reaction contained 3 μM 
of HPF and 20 μM of dye in a pH 7 sodium phosphate buffer (10 mM). The samples were 
irradiated at 780 nm for 15 min at room temperature, and then the enhancement of fluorescence 
relative to the background fluorescent of HPF was compared. using a spectrofluorometer. An 
Figure 51 Fluorescent spectra in HPF experiments. (A) HPF with Fenton reagent in D2O 
or H20, the final concentrations of reagents: 3 μM of HPF, 10 μM of H2O2, 10 μM of 
Fe(NH4)2(SO4)2, 10 mM sodium phosphate buffer of pH 7 (B) HPF with MB in D2O or 
H2O, the final conc. Of regents: 3 μM of HPF, 1 μM of methylene blue, 10 mM sodium 
phosphate buffer of pH 7. 
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excitation wavelength of 490 nm was employed, with emission at 515 nm indicating the presence 
of ROS.  
Positive and negative controls were prepared using reagents that specifically produce 
singlet oxygen and hydroxyl radicals. To generate singlet oxygen, 1 μM of methylene blue was 
added to a separate sample that contained 3 μM of HPF and was irradiated at 638 nm for 5 s. To 
further verify that methylene blue selectively produces singlet oxygen, two samples, one with 
H2O and other with D2O were prepared. It is expected that D2O enhances the life time of singlet 
oxygen and hence enhances the fluorescence signal as compared to H2O if only singlet oxygen is 
generated by methylene blue.98,99,100 Similarly, the Fenton reagent, (10 μM of H2O2 and 10 μM 
of Fe (NH4)2(SO4)2), a hydroxyl radical generator, was used as a positive control for the 
production of hydroxyl radicals. If hydroxyl radicals were to be produced during photo 
irradiation, then the HPF emission signal would go down or remain almost the same in D2O as 
compared to H2O. 
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The positive controls for the singlet oxygen and hydroxyl radicals in D2O and H2O are 
shown in Fig 51. The decrease in signal in D2O as compared to H2O in case of the Fenton 
reagent indicates the generation of hydroxyl radicals detected by the HPF probe. The increase in 
fluorescence intensity in case of D2O as compared to H2O for methylene blue indicates the 
production of singlet oxygen that can be detected by the HPF probe (Fig 51). 
Samples that contained 20 μM of dye 3 and 3 μM of HPF were irradiated at 780 nm for 
15 min at room temperature, and emission signal was recorded (Fig. 52). The enhancement of 
signal in both D2O and H2O indicates the generation of ROS. To further verify the type of ROS 
generated, D2O and H2O peaks intensities were compared. If the intensity of peak in H2O is 
lower as compared to D2O that could indicate the generation of singlet oxygen; however, in this 
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case, the intensity in H2O and D2O are similar. This indicates that singlet oxygen is not generated 
during the photo reaction with dye 3. Thus, since the emission signals are almost same in water 
and D2O (Fig 52 A) for dye 3 irradiated at 780 nm, it suggests that possibly there is only one 
species produced in the photo irradiation and that this species is the hydroxyl radical. 
 
 
 
 
 
 
 
 
 
 
 
 
To further confirm whether the produced ROS are hydroxyl radicals, sodium benzoate, 
which is a hydroxyl radical scavenger, was used. As a positive control, the intensity of Fenton 
reagent generated HPF fluorescence for hydroxyl radicals in presence and absence of 100 mM 
sodium benzoate was compared (Fig 52 C). The decrease in intensity of the peak when sodium 
benzoate was added indicates that hydroxyl radicals were scavenged. The same strategy was 
used for dye 3. Samples containing dye in the presence and absence of sodium benzoate were 
irradiated at 780 nm, and their fluorescence intensities were monitored (Fig 52 D). The decrease 
Figure 52 Experiments that show the generation of hydroxyl radicals in the 
photocleavage reactions. The samples were prepared by using final following 
concentrations: 20 μM of dye, 3 μM of HPF, 750 nM of SOSG, 100 mM of sodium 
benzoate, 10 μM of Fenton reagent, 10 mM sodium phosphate buffer of pH 7. 
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in fluorescence verifies that the photo reaction by dye produces hydroxyl radicals. Thus, it can be 
concluded that hydroxyl radicals are a main ROS involved in the DNA photocleavage reaction 
by dye 3.  
Singlet oxygen detecting probe 
Singlet oxygen sensor green (SOSG) was purchased and used as a fluorescent probe to 
determine if any singlet oxygen is produced during photocleavage reactions by dye 3. SOSG is a 
two-component trap fluorophore system. The mechanism of SOSG trapping of singlet oxygen is 
shown in Fig 53. SOSG prior to reaction with singlet oxygen is less fluorescent because of an 
intramolecular electron transfer from anthryl group to the light emitting fluorophore that 
quenches fluorescence. When reacted with singlet oxygen, the anthryl moiety of SOSG forms an 
endo peroxide, and the electron transfer is stopped. As a result, fluorescence is markedly 
enhanced. Several published studies are related to the selectivity and sensitivity of the SOSG. 
Golmers et al. and Ragas et al. studied the selectivity of SOSG as well as the possibility of self-
photosensitization and generation of singlet oxygen by SOSG. They found that SOSG is highly 
selective towards singlet oxygen and not responsive towards other ROS.101,102 They also reported 
that SOSG might produce singlet oxygen when photo-irradiated with UV or lower range visible 
light and suggested the use of proper control while designing the experiment. In this experiment, 
780 nm light was used to sensitize the ROS production by dye 3. Thus, this wavelength of light 
should not co-sensitize the ROS production by SOSG. 
To analyze the sensitivity and selectivity of SOSG, controls were prepared in 10 mM pH 
7 sodium phosphate buffer. Methylene blue, a singlet oxygen generator, was used as a positive 
control and the Fenton reagent, a hydroxyl radical generator, was used as a negative control. A 
1.25 mM stock solution of SOSG was prepared in methanol and stored in a -20 °C freezer. The 
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positive control was prepared in 10 mM pH 7 sodium phosphate buffer that contained 1 μM of 
methylene blue and 750 nM of SOSG. The fluorescence signal was weak for a methylene blue 
reaction kept in dark, but for a reaction irradiated with a 637 nm (300 mW) fluorescence signal 
went up significantly (Fig 53). Since methylene blue is a well-known for the production of 
singlet oxygen when irradiated with light, it acts as a reliable positive control for the SOSG.98,99 
The negative control for SOSG is a sample containing Fenton reagent, which produces hydroxyl 
radicals. Since SOSG is selective towards singlet oxygen, hydroxyl radicals, which are a highly 
reactive, short lived reactive oxygen species, cannot be detected by SOSG. Thus, Fenton reagent 
can be used as a negative control. Since the Fenton reagent did not enhance the signal, it can be 
concluded that SOSG is indeed selective towards singlet oxygen (Fig 53). 
 
 
 
 
 
 
 
 
 
 
The samples were prepared in 10 mM pH 7 buffer that contained 20 μM of dye 3 and 
0.75 μM of SOSG. The samples were then irradiated at 780 nm for 15 min at room temperature. 
The emission spectra were recorded with a PerkinElmer LS55 fluorescence spectrophotometer 
Figure 53 SOSG with positive control methylene blue 
and negative control Fenton reagent. The samples 
were prepared by using 750 nM of SOSG, 1 μM of 
methylene blue (MB), 10 μM of Fenton reagent in 
pH 7 sodium phosphate buffer (10 mM). 
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using an excitation wavelength of 480 nm. In Fig 52 B, the peak of the photo-irradiated sample 
and dark controls are of the same intensity. This confirms that there is no detectable singlet 
oxygen production in the photo reaction with dye 3. 
3.10 DNA photocleavage scavenger experiments 
The mechanism of photocleavage was further studied by using radical scavengers. All the 
samples contained 50 μM of dye, 38 μM bp of pUC19 in 10 mM pH 7 sodium phosphate buffer. 
Then a certain amount of scavenging reagents was added, and the samples were irradiated with a 
780 nm laser light for an hour at ~ 10 °C except for dark controls. After the photo irradiation was 
completed, the amount of photocleavage of supercoiled pUC19 DNA was monitored by agarose 
gel electrophoresis. The percentage of inhibition of photocleavage by each scavenging reagent 
was then calculated using the following formula: 
% photocleavage inhibition: 
[(X – Y)/X] * 100 
where X = % (nicked+linear) without scavenger, Y = % (nicked+linear) with scavenger 
Merkel and Kearns calculated the half-life of the singlet oxygen in H2O and in D2O and 
found that half-lives of the singlet oxygen in H2O and D2O are 2 μS and 20 μS respectively.
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This suggests that if the singlet oxygen is involved in a photo cleavage reaction, its lifetime can 
be enhanced by using D2O and the percentage of photo cleavage can be expected to increase. 
The photo cleavage reactions by dye 3 were conducted in 82 % (v/v) of D2O and in 100 % H2O 
(Fig 54). The percentage of inhibition or enhancement in DNA photo cleavage was calculated 
using the above formula. The result showed that there is no significant enhancement in photo 
cleavage by D2O as compared to H2O. This suggests that possibly there is no production of 
singlet oxygen in a photo cleavage reaction.  
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Another scavenger used was sodium azide, which is a singlet oxygen quencher.104 Singlet 
oxygen quenchers are supposed to inhibit a photo cleavage reaction if the photo cleavage is 
caused by singlet oxygen. A final concentration of 100 mM of sodium azide was added in a 
photo cleavage sample and irradiated with 780 nm light for an hour at ~ 10 °C. The result shows 
that there is no inhibition of photo cleavage as compared to the reaction without sodium azide 
(Fig 54). This result supported the SOSG result, which points to the non-involvement of singlet 
oxygen. Furthermore, there was a large enhancement of photo cleavage. This enhancement could 
give valuable information about the type of ROS involved in a photo cleavage reaction. Sing, 
Koroll and Cundall showed that azide radicals (N3) could be formed when sodium azide reacts 
with hydroxide radicals.105 According to them, the mechanism of formation of azide radicals 
involves the following steps. 
NaN3 (aq) Na
+ + N3
-(aq) 
N3
-(aq) + •OH (N3OH)
-• (aq) 
(N3OH)
-• (aq) N3
• + OH- (aq) 
This mechanism suggests that if there are hydroxyl radicals in an aqueous solution, a large 
number of azide radicals can be produced when sodium azide is added. Since azide radicals are 
also highly reactive, the enhancement of the photo cleavage reaction can be expected. This logic 
can explain the enhancement of photo cleavage in Fig 54, assuming there is a generation of 
hydroxyl radicals in a photo cleavage reaction. 
Sodium benzoate (final conc. = 100 mM), a hydroxyl radical scavenger, was also 
employed.106 An inhibition of photo cleavage was observed; suggesting that photo irradiation of 
dye 3 produces the hydroxyl radicals in a sample (Fig 54). The result is consistent with the HPF 
and SOSG probes results. Furthermore, inhibition in photo cleavage was observed when 100 mM 
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of the metal chelator EDTA was used in photo cleaving reactions. This suggests that a Fenton 
type reaction might be contributing hydroxyl radicals in the dye 3 photocleavage reactions. This 
solidifies the claim that hydroxyl radicals are the main ROS involved in DNA photo cleavage 
reactions. Catalase (2.5 U/μl), a hydrogen peroxide scavenger was also added in one sample to 
check for the participation of H2O2 in DNA photocleavage. A slight enhancement was observed, 
which could be due to the irons in the four heme units of catalase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54 Photocleavage experiments were conducted using ROS scavengers. Each 
sample contained 50 μM of dye, 38 μM bp of DNA in 10 mM pH 7 sodium phosphate 
buffer. A total of 82 % (v/v) of D2O was used in the D2O control reaction. The final 
concentrations of scavengers in the sam samples were 100 mM of sodium benzoate (SB), 
100 mM of sodium azide (SA), 100 mM of EDTA, and 2.5 U/μL of catalase. Each bar is 
the average of 3 trials. Error bars represents standard deviation. 
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3.11 Concentration-dependent photocleavage 
Concentration-dependent photocleavage reactions from 1 μM to 50 μM of dye 3 were 
conducted using 38 μM bp of pUC19 DNA at 10 mM pH 7 sodium phosphate buffer at ~ 10 °C. 
The percentage of photocleavage was higher in the case of 50 μM dye concentration as compared 
to others (Fig 55). Since the dye to DNA saturation concentration was 1:4, we did not try the 
photocleavage reactions by using more than 50 μM of a dye. 
 
 
 
 
 
 
These reactions were conducted for 30 min. The highest percentage of photocleavage for 
50 μM of dye might be explained by the possible binding of the dye in a way that generates a 
large amount of ROS.  
3.12 Ethidium bromide displacement microplate experiments 
Dye 3 was also tested for its binding preference with the AT-rich and GC rich duplex 
DNA by using an ethidium bromide displacement essay. Ethidium bromide, which is a high-
affinity intercalator, can also bind externally with DNA phosphate back bone with its phenyl and 
ethyl groups laying into the DNA major groove. The phenanthridinium ring of the ethidium 
bromide is also the heterocyclic ring of dye 3. Due to the structural similarities, it can be 
expected that there might be some relationship between the binding of ethidium bromide and dye 
Figure 55 Concentration dependent photocleavage of 38 μM bp of plasmid DNA over 
four trials. The samples were prepared in 10 mM pH 7 sodium phosphate buffer. Each 
reaction was irradiated for 30 min at ~10 °C by using 780 nm LED laser. 
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3. The displacement essay can also be used to calculate the binding affinity and could also 
provide valuable information about DNA binding modes. 
The samples were prepared in a 96-well Corning 25880 plate in 10 mM pH 7 sodium 
phosphate buffer with a fixed concentrations of DNA and dye and increasing concentration of 
ethidium bromide. The change in fluorescent intensity in each well as a function of ethidium 
bromide concentration was recorded using Fluostar microplate reader. The concentrations of the 
DNA and dye in each well were 20 μM bp and 25 μM respectively. In Fig 56 left, the 
experiment was conducted using CT-DNA with excitation and emission filters of 485 nm and 
520 nm respectively. The result shows that there is a significant quenching of the fluorescence of 
ethidium bromide in DNA-dye-EtBr samples as compared to DNA-EtBr samples. Though there 
was an apparent displacement of the dye when the ethidium bromide concentration was 
increased, the result could not explain the binding mode. 
 
 
 
 
 
 
 
 
 
 
 
Figure 56 Fluorescence intensity as a function of an increase in the concentration 
of ethidium bromide in samples containing 25 μM of dye and 20 μM bp of DNA in 
10 mM pH 7 sodium phosphate buffer. CT- DNA was used for the reactions in A. 
ATrich and GC rich DNA fragments were used for the reactions in B. 
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The displacement experiment was then conducted using PCR amplified AT-rich and GC 
rich sequences from pUC19 DNA. The primers were designed for a 66% AT rich 163 bp 
fragment and a 58% GC rich 162 bp fragments. After the PCR, the concentration of the 
amplified DNA was determined with a Nanodrop UV-visible spectrophotometer. Similar to the 
CT-DNA ethidium bromide experiment, the samples were prepared by using 25 μM of dye and 
20 μM bp of duplex DNA. The result gives valuable information regarding the binding mode of 
ethidium bromide (Fig 56 right). Ethidium bromide binds through intercalation in the DNA 
duplex but at higher concentration stacks along the DNA back bone with its substituents in the 
major groove. From Fig 56 right, it is clear that at low concentration ethidium bromide is 
binding to AT and GC rich polymer equally, indicating that EtBr is intercalating. At higher 
concentration, ethidium bromide prefers to bind into the GC rich fragment as compare to AT-
rich fragment. This might be because AT-rich major groove is blocked by methyl group of the 
thymine and GC rich major groove prefers to have cooperative stacking of the molecules in the 
groove.107 Again the displacement assay in this experiment could not be properly interpreted 
because of the ethidium fluorescence quenching by dye 3. The quenching of fluorescence can be 
observed when comparing the fluorescence intensity of the EtBr + dye 3 samples with the 
fluorescence intensity of EtBr. This suggests that because of the structural similarities of EtBr 
and dye 3, they may interact or stack together in an aqueous solution through hydrophobic 
means. 
3.13 Binding mode studies with 1H-NMR 
A 28-mer hairpin oligonucleotide was purchased from Integrated DNA Technology and 
was desalted using ClarionTM N5 columns purchased from Sorbtech. The purity of the 
98 
oligonucleotide was checked by denatured polyacrylamide gel electrophoresis and UV 
shadowing (Fig 57). 
 
 
 
 
 
The purified DNA was then lyophilized and dissolved in 90% DI water and 10% D2O for 
1H-NMR and dissolved in 100% D2O for NOESY experiments. A 500 MHZ-Bruker NMR 
spectrometer was used to record the NMR spectra. The 1D and 2D spectra were acquired using 
different drug-DNA ratios with an expectation of proton chemical shifts that might reveal DNA 
binding mode. 
According to the competitive UV-Visible displacement assay, competitive photo 
cleavage inhibition study, and circular dichroism study, the monomeric or low order aggregates 
form of dye 3 might be interacting with DNA in the major groove. 
The perturbation of the chemical shift or the peak broadening of the base pairs imino 
protons in NMR spectra could provide valuable information about the binding mode and 
specificity of a dye binding to DNA. Armitage and coworkers predicted the binding of a 
symmetrical cyanine dye in the minor groove of the duplex oligonucleotide based on the change 
in the chemical shift of the nucleotide base pairs protons. They monitored the C2 proton of 
adenine in the minor groove and found peak broadening when the dye was mixed with DNA. In 
addition to that, they also monitored the chemical shifts of imino proton of AT and GC base pairs 
and were able to tell the DNA binding preference of a dye.59 Nanjunda and Wilson discussed the 
Figure 57 28-mer oligonucleotide (right) and UV-shadow picture of 
denaturing PAGE of the oligonucleotide. 
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DNA groove shapes and chemistry in relation to binding of classical minor groove binders and 
small molecules. They talked about AT specificity of monomers and also said cooperative 
stacked dimers of heterocyclic diamidine have high binding affinity to GC. Furthermore, they 
also mentioned that the major and minor grooves of GC rich DNA are wider than AT-rich DNA 
and GC rich DNA favors the formation of stacked complexes.107 Taking into consideration these 
factors, the higher affinity of ethidium bromide towards GC rich DNA fragments as compared to 
AT-rich fragments in fluorescence microplate experiment makes sense at higher EtBr to DNA 
ratios. The same might be expected for the dye 3 as they have structural similarities. 
 
 
 
 
 
 
  
 
The samples for 1H proton NMR contained 100 μM of 28-mer hairpin DNA at pH 6.78 
sodium phosphate buffer (10 mM). Final concentrations of 20 mM of NaCl and 0.5 mM of 
EDTA were also added to the sample to stabilize the DNA base pairs. The experiment was 
conducted at 297 K, and the spectra were analyzed in the downfield region of proton chemical 
shifts. The chemical shift or peak broadening of imino proton was analyzed at different dye to 
DNA ratio. The assignment of the imino proton for AT and GC base pairs was done based on the 
Figure 58 Major groove and minor groove sides of AT and GC base pairs 
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Germann et al. paper.108 Similar methodology and peak assignment conventions were used by 
other scientists also when studying small molecule-DNA binding modes.109,110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The left two peaks belong to the imino protons of AT base pairs while the right three 
peaks belong to the imino protons of GC pairs of the hairpin (Fig 60). The drug to DNA ratios 
used were 1/4, 1/2 1/1, and 2/1. The 1/4 ratio represents the putative monomeric/low order 
aggregate form of DNA bound dye, whereas 2/1 ratio represents the H-aggregated form. When 
Figure 59 Tautomeric forms of DNA bases 
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the ratio of drug to DNA was increased, there was no significant chemical shift change, but only 
a broadening of the imino peaks in case of both AT and GC base pairs imino protons. This 
suggests that the dye is a non-sequence specific weak binder.  
 
 
 
 
 
 
 
 
 
 
 
In order to learn more about the binding modes of dye 3, an NOE experiment was 
conducted using D2O as a solvent. The sample contained 500 μM of oligonucleotide in a 10 mM 
sodium phosphate buffer with 20 mM NaCl and 0.5 mM EDTA. The pH* of the sample was 
adjusted to 6.45, and the spectra were recorded after adding 1 mM of dye. 
In Fig 61, the peaks at 7.4 and 7.55 are shifted when the dye is added. These peaks 
represents the proton chemical shifts of cytidine 6H or thymidine 6H.59,108 This change in the 
proton environment near the DNA phosphate back bone suggests that the dye is stacking weakly 
along the phosphate backbone either in the duplex region and/or loop region of the hairpin. The 
UV-visible and CD spectra recorded at a similar DNA to dye ratio suggest that the dye is binding 
Figure 60 1H NMR spectra that show imino protons at different drug-DNA ratios. The 
spectra were recorded by using Brucker 500 MHZ NMR spectrometer. 
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to DNA as H-aggregate. There was no perturbation in the chemical shift of thymidine methyl 
group which lies in the DNA major groove. This suggests that the dye is binding weakly and 
possibly binding externally to the DNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 CONCLUSIONS 
This research project was intended to find an ideal DNA photo-cleaving agent that has 
properties such as long wavelength absorption and DNA photocleavage, strong fluorescence, 
stability under physiological conditions, and robust DNA interactions. Several pentamethine 
bridged phenanthridinium cyanine dyes were chosen as possible candidates for the study. The 
Figure 61 2D NOE spectra of the 2:1 dye to DNA ratio recorded by Brucker 500 MHZ 
spectrometer. 
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halogenated analogs of dye 1 were synthesized, and their stabilities, photo cleaving efficiency, 
and DNA interactions were studied. These dyes were shown to damage DNA upon irradiation at 
780 nm, a wavelength that deeply penetrates biological tissue. The best DNA photo cleaver had 
hydrogen at the meso position of the polymethine bridge. Substituting H for Br slightly reduced 
photo cleavage yields while compound stability was markedly enhanced. Placing an electron-
withdrawing group at the meso position of the polymethine bridge of the dye may serve to 
minimize dye autoxidation.  
The kinetics of DNA photo cleavage showed that half-life of photo cleavage reactions 
follows in the order dye 2 > dye 4 > dye 3 > dye 1. The DNA binding affinities were ordered dye 
4 > dye 2 > dye 3. The dyes’ DNA Photocleavage efficiencies with 780 nm at ~ 10 °C were dye 
1 > dye 3 > dye 4 > dye 2. The stability of the dyes in 10 mM pH 7 sodium phosphate buffer 
were dye 4 ~ dye 2 ~ dye 3 > dye 1, and the stability of dyes in 10 mM pH 7 buffer in the 
presence of CT-DNA were dye 4 ~ dye 2 ~ dye 3 > dye 1. Taking consideration of these results, 
dye 3 was studied in detail because it affords the optimal balance between dye stability and 
photonuclease activity.  
CD and fluorescence data of dye 3 suggested that DNA interactions were non-
intercalative, possibly external or involving a DNA groove. UV-visible and ICD spectra indicate 
that at high dye to DNA ratios, dye 3 forms H-aggregates along the DNA but at low dye to DNA 
ratios, it binds either as a lower order aggregate or a monomer.  
 The mechanism and the species involved in the photo cleavage were studied using ROS 
detecting fluorescent probes HPF and SOSG. SOSG, which is a singlet oxygen-detecting probe, 
did not detect singlet oxygen in photocleavage reactions; however, HPF, which can detect both 
singlet oxygen and hydroxyl radicals, was able to detect ROS in irradiated samples of dye 3. This 
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suggests that singlet oxygen was not involved in the photo cleavage reaction. To further verify 
this result, sodium benzoate, a hydroxyl radical quencher, was added with the HPF in a dye 3 
sample and compared with the no sodium benzoate reaction. There was a significant decrease in 
signal, indicating that the hydroxyl radicals were produced by dye 3. Scavenging agents such as 
sodium azide, sodium benzoate, catalase, EDTA were added to DNA photo cleavage reactions, 
and the percentage of photo cleavage in presence and absence of scavengers was compared. The 
result coincided with the ROS probe experiments, furnishing strong proof that hydroxyl radicals 
contributed to DNA photocleavage by dye 3. 
DNA interactions of dye 3 were studied using competitive binding assays with ethidium 
bromide, an intercalator; pentamidine, a minor groove binder, and methyl green, a major groove 
binder. The result shows that ethidium bromide and methyl green afford significant displacement 
of dye 3 from DNA while pentamidine has no effect on the dye-DNA complex. In addition to 
that, a competitive photo cleavage inhibition study was conducted using these binders. The result 
shows that methyl green, which is a major groove binder, has higher inhibition, ethidium 
bromide has medium inhibition, and pentamidine, which is a minor groove binder, has no 
inhibition. The DNA affinities of the competitors are in the order ethidium bromide > 
pentamidine > methyl green. This suggests that dye 3 is possibly binding in or near the DNA 
major groove. An NMR study was conducted to further clarify the DNA binding mode. The 
result shows that the dye is binding weakly with possible external stacking of the molecules 
happening with their one end approaching the major groove. 
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5 CHAPTER 2: SINGLE PHOTON DNA PHOTOCLEAVAGE AT 830 NM BY 
QUINOLINE DICARBOCYANINE DYES 
(This chapter is taken verbatim from a submitted of the manuscript written by Dr. 
Kathryn B. Grant with assistance from Kanchan Basnet. The dyes under investigations (dye 4 
and dye 5) were synthesized by Dr. Maged Henary’s lab. UV-visible time course and scavengers 
experiments were conducted by Tayebeh Fatemipouya, circular dichroism and photocleavage 
experiments were performed by Kanchan Basnet and Tayebeh Fatemipouya, all other 
experiments were conducted by Kanchan Basnet). 
5.1 Abstract 
We have synthesized symmetrical carbocyanine dyes in which two 4-quinolinium rings 
are joined by a pentamethine bridge that is meso-substituted with H or Cl. Irradiation of the 
halogenated dye at 830 nm produces hydroxyl radicals that generate DNA direct strand breaks. 
This represents the first reported example of DNA photocleavage upon single photon excitation 
of a chromophore at wavelengths above 800 nm. 
5.2 Introduction 
Photodynamic therapy (PDT) is an emerging cancer treatment aimed at minimizing the 
side effects associated with traditional chemotherapeutic agents. In PDT, excitation of a 
photosensitizer (PS) with low energy light triggers the production of highly localized reactive 
oxygen species (ROS) in diseased tissues with minimal involvement of surrounding cells.1-3 In 
the most common PDT mechanism, singlet oxygen (1O2) is generated by Type 2 energy transfer 
between the triplet excited state (3PS*) of the PS and ground state triplet oxygen (3O2).
4 The 
triplet state can also react with 3O2 by Type 1 electron transfer to yield superoxide anion radicals 
(O2ˉ). Spontaneous dismutation of O2ˉ generates H2O2, which gives rise to hydroxyl radicals 
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(OH) via Fenton chemistry.4, 5 With respective diffusion distances of 50–100 nm6 and 0.8–6.0 
nm,7 the short-lived and highly reactive 1O2 and OH formed upon dye excitation cause 
extensive oxidative damage to DNA and other cellular macromolecules in their vicinity.8  
The clinical PDT agents porfimer sodium (Photofrin®), talaporfin (Aptocine™), and 
verteporfin (Visudyne®) directly sensitize genomic DNA cleavage when irradiated in tissue 
culture and/or in circulating cells.2 While their absorption bands are compatible with visible light 
sources that emit at wavelengths ≤ 689 nm, alternative photosensitizers with near-infrared 
maxima extending from ~700 nm to 900 nm are desired. This is due to enhanced penetration of 
incident irradiation afforded by minimal light absorption in this range by molecules in the body.9 
Thus, the light depth attained at 835 nm through biological tissue is approximately twice that at 
~630 nm, the wavelength used to activate porfimer sodium.1 
Although infrared light passes through tissues more efficiently, the result of red-shifting 
the λmax of a chromophore is to reduce triplet state energy.
10 This places limits on near-IR ROS 
production.5 For example, Type 2 singlet oxygen is generated only when a PS has a triplet state 
energy equivalent to or higher than the excitation energy of 1O2 (95 kJmol
-1, ~1270 nm).4 When 
taking into consideration the minimal energy gap (≤ 63 kJmol-1) between the first excited 1PS* 
and 3PS* states of PDT agents, this translates into an ~810 nm upper absorption limit for 1O2 
production.11 In order for a photosensitizer to form Type 1 superoxide, the oxidation potential of 
the PS triplet state should be higher than the oxidation potential of ground state triplet oxygen 
(E° (3O2/O2ˉ) = 0.16 V at pH 7.0),
12 but lowering triplet state energy inopportunely decreases 
excited state oxidation potentials.13 For the above reasons, there are relatively few examples of 
DNA photocleaving agents that are effective ROS generators in the near-infrared range.2 Until 
the present report, the longest wavelengths to trigger DNA strand scission upon direct, single 
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photon chromophore activation were all under 800 nm. In a seminal study, Chakravarty et al. 
cleaved plasmid DNA in high yield by employing an anthracenyl-bis(pyridyl)Fe(III) catecholate 
complex to photosensitize hydroxyl radical production with single photon 785 nm illumination.14 
 
 
 
 
 
Near-infrared cyanine dyes are currently being developed as PDT agents15 and are used 
in clinical settings as fluorescent probes in the diagnosis and imaging of cancer.16 DNA 
interactions are facilitated by the cyanines’ two flanking heteroaromatic nitrogen rings, which 
share a positive charge that is delocalized through a central polymethine bridge.17 DNA cleavage 
by hydroxyl radicals18 and singlet oxygen18-21 has been reported, with excitation wavelengths in 
the visible range19-21 up to 700 nm.18 A number of cyanine dyes, particularly those with 2-
quinolinium ring systems, avidly interact with the DNA minor groove as monomers, dimers, and 
higher order aggregates.17 In the design and syntheses of cyanine dyes 4 and 5 (Fig 62; Fig 68; 
Figs. S69 to S74), a red-shifting 4-quinolinium motif22 in combination with a highly conjugated 
central pentamethine bridge were selected to maximize light absorption in the near-infrared 
range (> 700 nm). Cyanines possessing extended polymethine chains can lose color in aqueous 
solutions due to spontaneous dye auto-oxidation (no hν).23 Substituting the H atom at the meso 
position of the pentamethine bridge of 4-quinolinium dye 4 with electron withdrawing Cl (5) was 
intended to reduce the dye oxidation process24 and, through a possible heavy atom effect, 
accelerate intersystem crossing rates from the singlet to the triplet excited PS state.25 
Figure 62 Chemical structures of the 4-quinolinium 
pentamethine carbocyanine dyes under study. 
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In UV-visible absorption spectra recorded over time, 4-quinolinium carbocyanines 4 and 
5 appeared to be stable in DMSO, with absorption maxima of 823 nm (4, X = H) and 795 nm (5, 
X = Cl) (Fig. S75; red lines in Fig. 63). In aqueous buffer however, the dyes exhibited markedly 
different signatures. The peak heights of the 823 nm and 795 nm absorption bands seen in 
DMSO were less prominent and new blue-shifted absorption maxima at 644 nm (4) and 546 nm 
(5) appeared (black lines in Fig. 63).26 In contrast to DMSO, the major bands of both cyanines 
lost intensity in the aqueous medium, although substitution of the meso hydrogen for Cl 
considerably slowed down the apparent dye auto-oxidation process (Fig. S76).  Interestingly, the 
addition of calf thymus (CT) DNA to the aqueous buffer appeared to stabilize the dyes, 
especially in the case of 5 (X = Cl), which in contrast to 4, exhibited little if any absorption loss 
over 25 min (Fig. 63). A second effect of DNA addition was to red-shift the long wavelength 
cyanine dye absorption maxima, e.g., from 801 nm to 826.5 nm (4, X = H); 780 nm to 805 nm 
(5, X = Cl). 
 
 
 
 
 
 
 
 
 
Figure 63 UV-visible spectra recorded at different time points for 10 μM of dyes 4  and 5 in: 
in DMSO (red line, t = 0 min) or in 10 mM sodium phosphate pH 7.0 buffer, without DNA 
(black line, t = 0 min) or with 150 μM bp CT DNA (blue line, t = 0 to purple line, t = 25 min). 
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The DNA-induced absorption changes shown in Fig 63 indicated that it should be 
possible to employ the 4-quinolinium dyes to sensitize photocleavage at near-infrared 
wavelengths  > 800 nm. Towards this end, cyanines 4 and 5 were equilibrated with pUC19 
plasmid and irradiated with 808 nm and 830 nm LED lasers (pH = 7.0). Duplicate sets of 
reactions were maintained at 10 °C (Fig. 64) and at 22 °C (Fig. S77) during irradiation. 
Additional samples were kept in the dark at 10 °C, 22 °C, and 37 °C (Fig. S78). DNA products 
resolved on agarose gels showed that 800 nm and 830 nm near-infrared light caused the dyes to 
convert uncut supercoiled plasmid to nicked DNA through the formation of direct strand breaks 
(Figs 64 and S75). Dye 4, which appears to spontaneously auto-oxidize in aqueous buffer (Figs. 
63 and 76), generated lower levels of photocleavage. Considerably more strand breakage was 
sensitized by the more stable halogenated dye (5; Figs. 64 and S77). Increasing the reaction 
temperature from 10 °C to 22 °C had no effect on cleavage yields. Moreover, minimal levels of 
strand breakage were observed in all of the dark control reactions containing dye, even after the 
temperature was increased from 10 °C to 37 °C. Taken together, the above results appear to rule 
against a thermal process and instead suggest that the DNA direct strand breaks produced by 
irradiating cyanine dyes 4 and 5 with 808 nm and 830 nm LED lasers is photochemical in nature. 
In our next experiment, plasmid samples containing 5 μM up to 50 μM of 4-quinolinium cyanine 
5 (X = Cl) were irradiated at 830 nm for 30 min. DNA cleavage was observed at the lowest dye 
concentrations tested (5 μM) and gradually increased until approaching a plateau at ~ 30 μM of 
dye (Fig. S79). When 20 μM reactions were irradiated as a function of time, DNA cleavage 
occurred up until the 120 min experimental endpoint (830 nm hν; Fig S80). To the best of our 
knowledge, the plasmid experiments reported in this paper constitute the first reported examples 
of DNA strand breakage upon single photon dye excitation at wavelengths above 800 nm. 
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The superior DNA photo-cleaving abilities of 5 led us to consider its DNA binding 
mode(s). In circular dichroism (CD) spectra of calf thymus (CT) DNA, the achiral cyanine 
generated an intense, bisignate induced CD (ICD) band indicative of exciton coupling (Fig. 65, 
black line). The band passes through zero ~ at the 547 nm absorption maximum of the DNA-
bound form of the chlorinated cyanine (Fig. 65, green line) and has an overall appearance 
consistent with the formation of a right-handed helical H aggregate in which cofacial cyanine 
dimers assemble in an end-to-end fashion in the DNA minor groove.27-29 UV-visible absorption 
titrations were then conducted in which small volumes of calf thymus (CT) DNA titrant were 
sequentially added to a solution containing a fixed amount of 5 (Fig. S81). A known effect of 
raising DNA concentration is to disrupt cyanine aggregation in favor of monomeric dye.27, 30 
Adding DNA to 5 increased the intensity of the dye’s 805 nm absorption maximum while 
Figure 64 Agarose gels showing cyanine dye-sensitized photocleavage of 
pUC19 plasmid DNA upon irradiation with 300 mW 808 nm (A) and 
830 nm (B) LED lamps (30 min hν at 10 °C). Reactions contained 10 
mM sodium phosphate buffer pH 7.0 and 38 μM bp DNA in the 
absence and presence of 20 μM of each dye. Yields and standard 
deviations are obtained over three trials. Abbreviations: L = linear; N = 
nicked; S = supercoiled. 
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decreasing the height of its 547 band. A similar change in absorption was observed when 
chlorinated cyanine 5 was moved from buffered aqueous solvent expected to promote dye 
aggregation (black line in Fig. 63B, no DNA) to DMSO, a polar organic solvent that stabilizes 
dye monomers (red line in Fig. 63B, no DNA).26 Taken together, the CD and UV-visible data 
suggest that the 547 nm absorption peak (Figs. 63B and 65) may arise from a DNA-bound H-
aggregate, while absorption at 805 nm represents DNA-bound monomer. For 5, the absence of 
an ICD signal corresponding to 805 nm absorption sheds light on a possible mode of DNA 
interaction of the putative monomeric dye form (Figs 65 and S82). While polymethine cyanines 
that engage in intercalation or groove binding typically generate ICDs, induced CD signals are 
frequently absent in the case of chromophores that bind to DNA in an external fashion.30-34  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 65 Double y-axis plots superimposing the circular dichroism (CD) and UV-visible 
absorption (Abs) spectra of dye 5 (22 °C). Samples contained 10 mM sodium phosphate 
buffer pH 7.0, 10 μM of dye and/or 120 μM bp (CD) to 150 μM bp (Abs) of CT DNA. 
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The fluorescence spectra of dye 5 (X = Cl) were recorded next (Fig. 66). Excitation 
wavelengths of 550 nm and 800 nm were selected to target the putative H-aggregated and 
monomeric dye forms, respectively. In the absence of DNA, 550 nm excitation resulted in little if 
any emission (red line in Fig. 66A). When DNA was present however, the dye became 
markedly fluorescent (dashed lines). Alternatively, no emission was observed under the 800 nm 
irradiation (Fig 66B). Upon DNA intercalation, the conformational mobility responsible for 
rapid non-radiative decay of cyanine dyes from singlet excited state is restricted, leading to large 
fluorescence enhancements.17, 30 The same principle has been applied to cyanine dyes that 
become emissive upon interacting with DNA in the minor groove.17 Taken together with the ICD 
spectra, the fluorescence data suggest that the putative dye monomers responsible for 805 nm 
cyanine absorption may be interacting with DNA in a conformationally flexible fashion distinct 
from classical minor groove binding and intercalation. While exciting the non-fluorescent dye 
monomer of 5 with 808 and 830 nm LED lasers sensitized plasmid DNA cleavage in good yields 
(Fig. 64), less strand breakage occurred under a 532 nm light source, possibly due to a depletion 
of excited state populations caused by the fluorescence of the corresponding putative DNA-
bound H aggregate (Fig. S83). 
Mechanisms contributing to DNA photocleavage were evaluated by using chemical 
agents to modulate direct strand break formation. Irradiating reactions in an argon-purged glove 
box reduced strand scission by 5 up to 75%, strongly implicated the involvement of ground state 
triplet oxygen (Table 1, Fig S84). A role for Type 1 hydroxyl radicals was then suggested by the 
OH scavenger sodium benzoate, which decreased photocleavage by  ~  40%. Although DNA 
strand scission was inhibited by the popular Type 2 singlet oxygen scavenger sodium azide, 
cleavage was supressed when H2O was replaced with D2O, a solvent that produces a 10-fold 
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enhancement in the lifetime of singlet oxygen (Table 1, Figs S85 and S86).35 This rules against 
1O2 as a contributing ROS and instead points to the residual ability of sodium azide to react with 
Type 1 OH.36 To confirm ROS involvement, we used the fluorescence probes 3’-(4-
hydroxyphenyl)fluorescein (HPF) to detect hydroxyl radicals and Singlet Oxygen Sensor 
Green® (SOSG) to trap 1O2..
37
 In preliminary controls, hydroxyl radicals generated by the Fenton 
reagent (ammonium iron(II) sulfate + H2O2) and singlet oxygen photosensitized by methylene 
blue38 were detected by HPF and SOSG, respectively (Fig S87). Upon irradiating the cyanine 
dye at 830 nm, there was a substantial increase in fluorescence when HPF was present in the 
reaction, vs. a small decrease in the case of SOSG (Fig 67). Finally, adding the hydroxyl radical 
scavenger sodium benzoate significantly reduced HPF signal intensity. Considered together with 
the data in Table 1, the fluorescence experiments point to hydroxyl radicals as the primary ROS 
responsible for the near-infrared DNA photocleavage sensitized by chlorinated cyanine dye 5. 
 
 
 
 
 
 
 
 
 
 
 
Figure 66 Double y-axis plots superimposing the fluorescence emission (Em) and 
UV-visible absorption (Abs) spectra of dye 5 (22 °C). Samples contained 10 mM 
sodium phosphate buffer pH 7.0, 10 μM (Em) or 20 μM (Abs) of dye and/or 100 
μM to 990 μM bp of CT DNA. The emission spectra were recorded at excitation 
wavelength (Ex) of 550 nm (A) and 800 nm (B). 
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In summary, we have synthesized two symmetrical carbocyanine dyes in which dual 4-
quinolinium rings are linked to a pentamethine bridge meso-substituted with either H (4) or Cl 
(5). The electron withdrawing chlorine atom substantially stabilizes dye 5 in aqueous buffer. 
Table 1 Inhibition of dye 5 photocleavage induced by chemical 
additives 
Reagents added Target ROS 
Photocleavage inhibition 
(%) 
   
Argon  1O2 & •OH 75 ± 3 
Sodium benzoate  •OH 40 ± 2 
Sodium azide 1O2 > •OH 24 ± 2 
D2O  
1O2 12 ± 1 
 
a Reactions consisting of 38 μM bp of pUC19 plasmid DNA 
equilibrated with 20 μM of 5 with and without 100 mM of 
scavenger or 70% D2O (v/v) were irradiated for 30 min with a 830 
nm, 300 mW LED laser (10 mM sodium phosphate buffer pH 7.0; 
Figs. S15 - S17). Data were averaged over three trials with error 
reported as standard deviation.  
Figure 67 Fluorescence spectra recorded in 10 mM sodium phosphate 
buffer pH 7.0 in the absence and presence of 20 μM of 5 and: (A) 3 μM 
of hydroxyphenyl fluorescein (HPF; λex = 490 nm) without and with 100 
mM sodium benzoate (SB); (B) 0.75 μM Singlet Oxygen Sensor Green 
(SOSG); λex = 480 nm). Reactions were kept in the dark or irradiated 
(hν) at 830 nm for 30 min (22 °C). 
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When bound to DNA in a conformationally flexible, monomeric fashion, single photon 830 nm 
excitation of the dye generates OH radicals that produce direct strand breaks in plasmid DNA 
(pH 7.0, no piperidine or base). This is significant not only because 830 nm light deeply 
penetrates biological tissue, but also because of the intrinsic limitations on ROS production 
imposed by the low excited state energies of many near-IR chromophores. Our findings suggest 
that 4-quinolinium-based carbocyanine dyes may have the potential to serve as hydroxyl radical 
sensitizing agents in near-infrared phototherapeutic applications. 
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6 SUPPLEMENTARY INFORMATION: 
(A)Experimental Section 
 
General  
 
Deionized distilled water was used for buffer and DNA sample preparation. PUC19 
plasmid DNA was cloned in XL-1 blue E. coli competent cells (Stratagene) according to 
standard laboratory protocols1 and was purified using a QIAfilter Plasmid Mega Kit (Qiagen™, 
Cat. No. 12263). Sonicated calf thymus (CT) DNA was obtained from Invitrogen (Cat. No. 
15633-019; 10 mg/mL, average size ≤ 2000 bp). Sodium phosphate monobasic and sodium 
phosphate dibasic came from Thermo Fisher Scientific. Deuterium oxide (99.9%) was supplied 
by Cambridge Isotope Laboratories. All other chemicals, including sodium azide (≥99.99%), 
sodium benzoate (99%), and dimethyl sulfoxide (DMSO, ≥99.99%) were from Sigma-Aldrich 
and were used as-is without further purification. 
A PerkinElmer Lambda 35 spectrophotometer or a Shimadzu UV-2401 PC 
spectrophotometer and a PerkinElmer LS55 fluorescence spectrophotometer were respectively 
used to record UV-visible absorption spectra and fluorescence emission spectra. Circular 
dichroism (CD) and induced circular dichroism (ICD) spectra were acquired with a Jasco J-810 
or a Jasco J-1500 CD spectropolarimeter. At wavelengths from 700 nm to 1000 nm, the Jasco J-
1500 spectropolarimeter was fitted with a Jasco EXPM-531 NIR extender to enhance the 
sensitivity of the CD signal. NMR spectra were recorded on a Bruker Advance 400 MHz NMR 
spectrometer. High-resolution mass spectra (HRMS) were obtained from the Georgia State 
University Mass Spectrometry Facility using a Waters Q-TOF micro (ESI-Q-TOF) mass 
spectrometer. All melting points were recorded on a Mel-Temp Electrothermal apparatus and are 
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uncorrected. Pre-coated Silica GEL 60 F-254TLC plates were from Merck KGaA (Darmstadt, 
Germany). 
Synthetic procedures 
4-methylquinolinium iodide (1): Quinolinium salt 1 (Scheme S1) was obtained by the 
reaction of 4-methylquinoline (1 equiv) with iodomethane (4 equiv) in anhydrous acetonitrile 
refluxed at 90° C for 72 h.  Thin layer chromatography (TLC) was used to monitor the progress 
of the reaction eluting with a 4:1 mixture of DCM:hexanes. Upon completion, the reaction 
mixture was allowed to cool to room temperature and diethyl ether was added to precipitate the 
iodide salt. The solid was collected by vacuum filtration and washed with diethyl ether (3x25 
mL). The salt was used without further purification in subsequent reactions. 
General procedure for the synthesis of polymethine precursors  
Polymethine precursor 3 (Scheme S1) was purchased from Sigma Aldrich and used as-is. 
Precursor 2 was prepared as described previously.2 Briefly, mucochloric acid (1 equiv) was 
dissolved in ethanol. A solution of aniline (2 equiv) was added dropwise over 10 min, and the 
resulting mixture was stirred and heated to 40 °C until the evolution of CO2 (g) was observed to 
cease. The mixture was then cooled in an ice bath and diethyl ether was slowly added to induce 
precipitation of the reaction product. The resulting solid was collected by vacuum filtration, 
washed with diethyl ether (3x25 mL), and used without any additional purification. 
General procedure for the synthesis of dyes 4 and 5 
The final dyes 43 and 54 (Scheme S1) are reported in the literature; however, the 
publications fail to provide any synthetic methods or characterization of the compounds or 
provide only superficial characterization (UV-visible spectra). Due to this, we are reporting these 
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compounds with the characterization included. For dye 5, solubility in deuterated solvents 
proved too poor to obtain sufficient concentrations of the compound for 13C NMR spectroscopy. 
Salt 1 (2 equiv) and the corresponding polymethine precursors 2 or 3 (1 equiv) were 
dissolved in acetic anhydride. Trimethylamine (TEA) (0.1 mL) was added and the reaction 
mixture was stirred and heated to 75 °C. Reaction progress was monitored by UV-visible 
spectrophotometry. Upon completion of the reaction, diethyl ether was added to precipitate the 
final dyes 4 and 5, which were collected by vacuum filtration. The dyes were purified by 
recrystallization from methanol/diethyl ether. 
1-methyl-4-((1E,3E)-5-((Z)-1-methylquinolin-4(1H)-ylidene)penta-1,3-dien-1-
yl)quinolin-1-ium iodide (4): MP 239 °C (Dec); 1H NMR (400 MHz, DMSO-d6) δ ppm 3.97 (s, 6 
H) 6.65 (t, J = 12.25 Hz, 1 H) 6.99 (d, J = 13.39 Hz, 2 H) 7.32 (d, J = 7.33 Hz, 2 H) 7.59 (t, J = 
7.07 Hz, 2 H) 7.78 - 7.89 (m, 4 H) 7.95 (t, J = 13.01 Hz, 2 H) 8.09 (d, J = 7.07 Hz, 2 H) 8.42 (d, 
J = 8.34 Hz, 2 H); 13C NMR (100 MHz, DMSO-d6) δ ppm 41.47, 107.80, 110.48, 117.22, 
118.93, 124.18, 124.74, 125.90, 128.62, 132.46, 138.86, 141.36, 145.80, 146.89; HRMS (TOF 
MS ESI+): calc’d for C25H23N2
+: m/z 351.1856 ([M]+), Found: m/z 351.0218 [M]+ 
4-((1E,3Z)-3-chloro-5-((Z)-1-methylquinolin-4(1H)-ylidene)penta-1,3-dien-1-yl)-1-
methylquinolin-1-ium iodide (5): MP >260 °C; 1H NMR (400 MHz, DMSO-d6) δ ppm 4.05 (s, 6 
H) 6.94 (d, J = 13.14 Hz, 2 H) 7.41 (d, J = 7.33 Hz, 2 H) 7.67 (t, J = 5.81 Hz, 2 H) 7.86 - 7.97 
(m, 4 H) 8.14 (d, J = 12.88 Hz, 2 H) 8.30 (d, J = 7.07 Hz, 2 H) 8.41 (d, J = 8.34 Hz, 2 H); HRMS 
(TOF MS ESI+): calc’d for C25H22ClN2
+: m/z 385.1466 ([M]+), Found: m/z 385.1964 [M]+ 
Cyanine dyes 4 and 5 were stored in a -4 °C freezer as concentrated stock solutions in 
DMSO. 
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UV-visible absorption spectrophotometry, dye stability and DNA interactions  
The absorbance of cyanine dyes 4 and 5 was measured at 22 °C with a UV-visible 
spectrophotometer. Cuvettes contained 10 μM of dye in DMSO or 10 μM of dye in 10 mM of 
sodium phosphate pH 7.0 buffer without and with 150 μM bp CT DNA. Absorption spectra were 
recorded at 5 min time intervals from 0 min up to 25 or 30 min. 
In DNA titration experiments, small volumes of an aqueous solution of 15,111 μM bp CT 
DNA were sequentially added to samples containing 20 μM of cyanine dye in 10 mM sodium 
phosphate buffer pH 7.0 (500 μL initial volume). All absorption spectra were corrected for 
sample dilution. Final concentrations of CT DNA in each sample ranged from 0 μM bp up to 
2684 μM bp.  
DNA photocleavage 
Individual DNA cleavage reactions containing 5 μM to 50 μM concentrations of cyanine 
dye 4 or 5, 38 μM bp of pUC19 plasmid, and 10 mM of sodium phosphate pH 7.0 were prepared 
in a total volume of 40 μL. In order maintain reaction temperature at 10 °C, 22 °C, or 37 °C, the 
samples were placed in a thermometer-fitted metal block that was either heated, kept at room 
temperature, or immersed in an ice bath. While monitoring temperature with the thermometer, 
the samples were either kept in the dark or were irradiated at time interval ranging from 5 min to 
120 min using a light emitting diode (LED) laser (LaserLands) with a peak emission wavelength 
of either 532 nm (100 mW), 808 nm (300 mW), or 830 nm (300 mW). At the end of the 
irradiation time interval, a total of 3 µL of electrophoresis loading buffer containing 15.0% (w/v) 
ficoll and 0.025% (w/v) bromophenol blue) was added to each reaction and 20 µL of the 
resulting solution were added to one of the wells of 1.5% agarose gel stained with ethidium 
bromide (0.5 μg/mL, final concentration). Completely loaded gels were then electrophoresed for 
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~60 min at 105 V in a Bio-Rad Laboratories gel box using 1 × tris-acetate-EDTA (TAE) 
containing 0.5 μg/mL ethidium bromide as the running buffer. Electrophoresed gels were 
visualized at 302 nm with a VWR Scientific LM-20E transilluminator and then photographed 
with a UVP PhotoDoc-It™ Imaging System. For quantitating the gels, ImageQuant version 5.2 
software was employed. The DNA photocleavage yields were then calculated using the formula:  
Percent Photocleavage = [(Linear + Nicked DNA)/(Linear + Nicked + Supercoiled 
DNA)] × 100. 
Circular dichroism 
Individual samples for CD analysis consisted of 10 mM sodium phosphate buffer pH 7.0 
with 10 µM of dye and 120 µM of CT-DNA present alone and in combination (total volume of 
2000 µL). Spectra were collected from 900 to 200 nm in 3 mL (1.0 cm) quartz cuvettes (Starna) 
using the following instrument settings: scan speed, 100 nm/min; response time, 2 s; bandwidth, 
0.5 nm; sensitivity, 100 millidegrees. Final spectra were averaged over 12 acquisitions. 
Extended, near-infrared circular dichroism spectra were recorded from 1000 nm to 600 
nm for samples containing 10 mM sodium phosphate buffer pH 7.0, 25 µM of dye, and 990 µM 
bp of CT DNA (2000 µL total volume). The scan speed was set at 100 nm/min, the response 
time was 2 s, and the bandwidth and sensitivity were 0.5 nm and 200 millidegrees, respectively. 
Final spectra were averaged over 12 acquisitions. 
Fluorescence emission spectra  
Solutions containing 10 mM sodium phosphate buffer pH 7.0 and 10 μM of cyanine dye 
in the absence and presence of either 100 μM bp or 990 μM bp CT DNA were transferred to 3.0 
mL Starna quartz cuvettes (2000 μL, total volume). The samples were excited at 550 nm and 800 
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nm and emission spectra were respectively recorded from 555 nm to 900 nm and from 805 nm to 
900 nm (22 °C). 
Reagent induced changes in DNA photocleavage 
In an argon-purged glove box, 40 µL photocleavage reactions containing 10 mM sodium 
phosphate buffer pH 7.0, 20 μM of cyanine dye, and 38 μM bp of pUC19 plasmid were prepared 
from solutions bubbled with argon and then irradiated at 830 nm for 30 min. The procedure was 
repeated using aerated solutions in a glove box purged with air.  
A second set of reactions containing 10 mM of sodium phosphate buffer pH 7.0, 38 µM 
bp pUC19 plasmid DNA and 20 µM of dye were prepared in the presence and absence of either 
100 mM of the singlet oxygen scavenger sodium azide, 100 mM of the hydroxyl radical 
scavenger sodium benzoate, or 70% D2O (v/v). The reactions were aerobically irradiated on the 
bench top for 30 min (830 nm). 
After the irradiation, the above DNA reactions were electrophoresed on 1.5% non-
denaturing agarose gels, visualized, and quantitated as just described. The percent change in 
DNA photocleavage was then calculated using the following formula, where the additive was 
either argon, sodium azide, sodium benzoate, or D2O: 
Percent Change in Cleavage = [(% Total of Linear and Nicked DNA with additive – % Total 
of Linear and Nicked DNA without additive)/(% Total of Linear and Nicked DNA without additive)] x 100. 
ROS detection using HPF 
Solutions containing 10 mM sodium phosphate buffer pH 7.0, and 3 μM of 
hydroxyphenyl fluorescein (HPF) in the presence and absence of 20 μM of 5 were prepared. In a 
parallel reaction, a total 100 mM of sodium benzoate was used as a hydroxyl radical scavenging 
reagent. Samples were then kept in the dark or irradiated with an 830 nm LED laser (power = 
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300 mW/cm2) for 30 min. To generate hydroxyl radicals, aqueous solutions containing 10 μM 
H2O2, 10 μM ammonium iron(II) sulfate, 3 μM HPF, and 10 mM sodium phosphate buffer pH 
7.0 in the presence and absence of 100 mM of sodium benzoate were equilibrated in the dark for 
a few minutes (22 °C).5 Fluorescence emission spectra were immediately recorded using a 
PerkinElmer LS55 spectrofluorometer (λex = 490 nm).  
ROS detection using SOSG 
Reactions containing 10 mM sodium phosphate buffer pH 7.0 and 0.75 μM of Singlet 
Oxygen Sensor Green (SOSG) in the presence and absence of 20 μM of 5 were prepared. 
Samples were then kept in the dark or irradiated with an 830 nm LED laser (power = 300 
mW/cm2) for 30 min. As a positive control for hydroxyl radical detection, an aqueous solution 
containing 10 μM H2O2, 10 μM ammonium iron(II) sulfate, 750 nM of SOSG, and 10 mM 
sodium phosphate buffer pH 7.0 was equilibrated in the dark for a few minutes (22 °C).5 To 
generate singlet oxygen, solutions containing 1 μM of methylene blue and 10 mM sodium 
phosphate buffer pH 7.0 were kept in the dark or irradiated with a 300 mW 638 nm LED laser 
(LaserLands) for 2 s.  Fluorescence emission spectra were immediately recorded with a 
PerkinElmer LS55 spectrofluorometer (λex = 480 nm).  
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(B) Supporting Figures: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 68 Synthesis of cyanine dyes 4 and 5. 
Figure 69 1H NMR spectrum of dye 4. 
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Figure 71 13C NMR spectrum of dye 4. 
Figure 70 13C NMR spectrum of dye 4. 
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Figure 72 HRMS of dye 4. 
Figure 73 1H NMR spectrum of dye 5. 
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Figure 74 HRMS of dye 5. 
Figure 75 UV-visible spectra recorded as a function of time for 10 μM of dyes 4 and 5 
in DMSO (22 °C). 
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Figure 76 UV-visible spectra recorded as a function of time for 10 μM of dyes 4 and 
5 in 10 mM sodium phosphate pH 7.0 buffer (22 °C). 
Figure 77 Agarose gels showing cyanine dye-sensitized photocleavage of 
pUC19 plasmid DNA with 300 mW (A) 808 nm and (B) 830 nm LED 
lamps (30 min hν at 22 °C). Reactions contained 10 mM sodium 
phosphate buffer pH 7.0 and 38 μM bp DNA in the absence and 
presence of 20 μM of dye. Yields and standard deviation were obtained 
over 3 trials. (Abbreviations: L = linear; N = nicked; S = supercoiled). 
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Figure 78 Agarose gels showing controls in which cyanine dyes 4 and 5 were 
equilibrated with pUC19 plasmid DNA in the dark at temperatures ranging 
from 10 °C to 37 °C (30 min no hν). The reactions contained 10 mM sodium 
phosphate buffer pH 7.0 and 38 μM bp DNA in the absence and presence of 
20 μM of dye. 
 
Figure 79 Agarose gel (A) and corresponding yields (B) showing 
photocleavage of 38 µM bp pUC19 DNA by 0 to 50 μM of dye 5 (10 mM 
sodium phosphate buffer pH 7.0). With the exception of the dark controls in 
lane 1, reactions were irradiated with a 300 mW 830 nm LED lamp for min at 
22 °C. 
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Figure 80 Photocleavage of 38 µM bp pUC19 DNA by 20 μM of dye 5 
(10 mM sodium phosphate buffer pH 7.0). Reactions were irradiated 
with a 300 mW 830 nm LED lamp for 0, 1, 5, 10, 15, 20, 25, 30, 60, 90, 
and 120 min time intervals at 10 °C. Data points are averaged over 
three trials. Error bars represent standard deviation. Abbreviations: 
N = nicked; S = supercoiled. 
Figure 81 Representative UV-visible absorption titration 
spectra of 20 μM of cyanine dye 5 in the absence and 
presence of increasing concentrations of CT DNA (10 mM 
sodium phosphate buffer, pH 7.0, 22 °C). All absorption 
spectra were corrected for sample dilution. 
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Figure 82 Double y-axis plots superimposing the extended, near-
infrared circular dichroism (CD) and UV-visible absorption (Abs) 
spectra of dye 5 (22 °C). Samples contained 10 mM sodium phosphate 
buffer pH 7.0, 20 μM (Abs) or 25 μM (CD) of dye and 990 μM bp of CT 
DNA. 
Figure 83 Agarose gels showing cyanine dye-
sensitized photocleavage of pUC19 plasmid DNA (A) 
after 30 min of irradiation with a 100 mW 532 nm 
LED laser and (B) after a 30 min incubation period 
in the dark (10 °C). Reactions contained 10 mM 
sodium phospha phosphate buffer pH 7.0 and 38 μM 
bp DNA in the absence and presence of 20 μM of dye 
5. Abbreviations: N = nicked; S = supercoiled). 
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Figure 84 Agarose gel showing cyanine dye-sensitized photocleavage of 
pUC19 plasmid DNA under aerobic and anaerobic conditions. Reactions 
containing 10 mM sodium phosphate buffer pH 7.0, 20 μM of dye 5, and 
38 μM bp DNA were purged with air or argon and then either irradiated 
with a 300 mW 830 nm LED lamp or kept in the dark in a gas-purged 
glove box (30 min, 22 C). Abbreviations: L = linear; N = nicked; S = 
supercoiled. 
 
Figure 85 Agarose gels comparing levels of cyanine dye-sensitized 
photocleavage of pUC19 plasmid DNA generated in the absence 
(A) and presence of the ROS scavenging agents sodium benzoate 
(B), and sodium azide (C) (830 nm hν for 30 min at 22 °C). All 
reactions contained 10 mM sodium phosphate buffer pH 7.0, 20 
μM of dye 5, and 38 μM bp DNA. Abbreviations: L = linear; N = 
nicked; S = supercoiled. 
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Figure 86 Agarose gels showing cyanine dye-sensitized 
photocleavage of pUC19 plasmid DNA in 100% H2O (v/v) (A) 
vs. 70% D2O (v/v) (B). The reactions, which contained 10 mM 
sodium phosphate buffer pH 7.0 and 38 μM bp DNA in the 
absence and presence of 20 μM of dye 5, were either kept in the 
dark or irradiated with a 300 mW 830 nm LED lamp (30 min 
hν at 22 C). Abbreviations: L = linear; N = nicked; S = 
supercoiled. 
 
Figure 87 Fluorescence spectra recorded at 22 ºC of: (A) 3 μM hydroxyphenyl 
fluorescein (HPF) in the absence (black line) and presence of either 10 μM 
ammonium iron(II) sulfate/10 μM H2O2 (red line) or 10 μM ammonium iron(II) 
sulfate/10 μM H2O2 and 100 mM sodium benzoate (SB; blue line); (B) 0.75 μM 
Singlet Oxygen Sensor Green (SOSG) in the absence (purple line) and presence 
of either 10 μM ammonium iron(II) sulfate/10 μM H2O2 (green line), 1 μM 
methylene blue (black line),  or 1 μM methylene blue irradiated for 2 s with a 300 
mW 638 nm LED laser (Laserlands; red line). All samples contained 10 mM 
sodium phosphate buffer pH 7.0. 
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7 CHAPTER 3: CONCLUSION AND FUTURE STUDIES 
In this research project, we have studied in detail about the phenanthridinium and 
quinolinium pentamethine cyanine dyes structure-stability relationships, DNA interactions and 
mechanisms, DNA photocleavage and kinetics, fluorescence capabilities, and ROS species 
involved in DNA damage. The first chapter of the dissertation presents the research done on four 
pentamethine phenanthridinium dye analogs while the second chapter focuses on two 
pentamethine quinolinium dyes. 
In both class of dyes, the halogen-substituted analogs were found to be relatively stable in 
aqueous buffer as compared to their unsubstituted counterpart. Similarly, when DNA was added 
to the dyes’ aqueous solutions, it was observed that DNA markedly enhanced the stability of the 
dyes. 
DNA photocleavage studies were conducted for all the dyes. It was found that the 
phenanthridinium dyes were capable of damaging the DNA at or up to 780 nm while 
quinolinium dyes cleaved DNA at or up to 830 nm. These wavelengths (780 nm and 830 nm) lie 
right in the phototherapeutic window, which enables the dyes to be considered as candidate 
phototherapeutics agents in photodynamic therapy. 
DNA interaction studies conducted using spectroscopic methods suggested that the 
phenanthridinium series lead dye 3 binds to DNA as a lower order aggregate or a monomer when 
the dye-DNA ratio is low. At high dye-DNA ratios, this dye binds as an H-aggregate in a DNA 
groove, possibly the major groove. Similarly, spectroscopic experiments were conducted to find 
the DNA binding modes of dye 5, the lead dye of the quinolinium series. The result suggests that 
this dye also forms H-aggregates along the DNA at high dye-DNA ratios and possibly binds as 
an external monomer when the dye-DNA ratio is low. Phenanthridinium dye 3 and quinolinium 
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dye 5 are respectively substituted with bromine and chlorine atoms at the meso position of the 
pentamethine bridge. 
Fluorescence spectrophotometric studies were conducted with dye 3 of the 
phenanthridinium series. This dye was not fluorescent in the presence and absence of DNA in 
aqueous buffer. Similar experiments were conducted with dye 5, the quinolinium dye and the 
result showed that the dye 5 is fluorescent when bound to DNA as an H-aggregate. 
The ROS detecting probes HPF and SOSG were employed to identify the ROS generated 
when the dyes were irradiated in aqueous buffer. Both dyes, dye 3 (irradiation wavelength = 780 
nm) and dye 5 (irradiation wavelength = 830 nm), generated hydroxyl radicals when they were 
photosensitized. No singlet oxygen was found. 
Since dye 3 and dye 5 photo damage the DNA in near infrared wavelength range, they 
could be further studied for their possible use in photodynamic therapy. Photosensitizers in PDT 
are believed to have properties such as minimal dark toxicity, selective retention in tumor cells, 
NIR absorption, stability under physiological conditions, and the ability to generate photo 
damage in diseased cells. In this project, we studied dye stability, DNA photocleavage kinetics, 
and mechanism of dye-DNA interactions in vitro. In future, the dyes’ safety and efficacy should 
be tested in animals in addition to their toxicities, pharmacokinetics, and pharmacodynamics 
properties. 
 
